Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 25
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Towards a European health research and innovation cloud (HRIC)

  • Aarestrup, Frank M.
  • Gut, Ivo Glynne
  • Sanz, Ferran
  • Van Oyen, Herman
The European Union (EU) initiative on the Digital Transformation of Health and Care (Digicare) aims to provide the conditions necessary for building a secure, flexible, and decentralized digital health infrastructure. Creating a European Health Research and Innovation Cloud (HRIC) within this environment should enable data sharing and analysis for health research across the EU, in compliance with data protection legislation while preserving the full trust of the participants. Such a HRIC should learn from and build on existing data infrastructures, integrate best practices, and focus on the concrete needs of the community in terms of technologies, governance, management, regulation, and ethics requirements. Here, we describe the vision and expected benefits of digital data sharing in health research activities and present a roadmap that fosters the opportunities while answering the challenges of implementing a HRIC. For this, we put forward five specific recommendations and action points to ensure that a European HRIC: i) is built on established standards and guidelines, providing cloud technologies through an open and decentralized infrastructure; ii) is developed and certified to the highest standards of interoperability and data security that can be trusted by all stakeholders; iii) is supported by a robust ethical and legal framework that is compliant with the EU General Data Protection Regulation (GDPR); iv) establishes a proper environment for the training of new generations of data and medical scientists; and v) stimulates research and innovation in transnational collaborations through public and private initiatives and partnerships funded by the EU through Horizon 2020 and Horizon Europe., The workshop participants received funding from the European Union Seventh Program for Research, Technological Development and Demonstration (FP7) and Horizon Research and Innovation Program (H2020) and other European Union programs under the following grant agreements: AETIONOMY (Developing an Aetiology-based Taxonomy of Human Disease—Approaches to Develop a New Taxonomy for Neurological Disorders, IMI-no115568), ANTI-SUPERBUG PCP (ANTISUPERBUG Precommercial Procurement, H2020-no688878), B-CAST (Breast CAncer Stratification understanding the determinants of risk and prognosis of molecular sub-types, H2020-no633784), BRIDGE Health (Bridging information and data generation for evidence-based health policy and research, H2020-no664691), CASyM (Coordinating Action Systems Medicine—Implementation of Systems Medicine across Europe, FP7-n°305033), CENTER-TBI (Collaborative European NeuroTrauma Effectiveness Research in TBI, FP7-no602150), CECM (Centre for New Methods in Computational Diagnostics and Personalized Therapy, H2020-no763734), COLOSSUS (Advancing a Precision Medicine Paradigm in Metastatic Colorectal Cancer: Systems based patient stratification solutions, H2020-no754923), COMPARE (COllaborative Management Platform for detection and Analyses of (Re-)emerging and foodborne outbreaks in Europe, H2020-no643476), CONNECARE (Personalized Connected Care for Complex Chronic Patients, H2020-no689802), CREATIVE (Collaborative REsearch on ACute Traumatic brain Injury in intensiVe care medicine in Europe, FP7-no602714), DEFORM (Define the global and financial impact of research misconduct H2020-no710246), ECCTR (European Cornea and Cell Transplant Registry, FP7-n°709723), E-COMPARED (European COMPARative Effectiveness Research on online Depression, FP7-no603098), ECRIN-IA (European Clinical Research Infrastructures Network- Integrating Activity, FP7-no284395), EHR4CR (Electronic Health Records Systems for Clinical Research, IMI-no115189) eInfraCentral (European E-infrastructures Services Gateway, H2020-no731049), ELIXIR (European Life-science Infrastructure for Biological Information, FP7-n°211601), ELIXIR-EXCELERATE (Fast track ELIXIR implementation and drive early user exploitation across the life sciences, H2020-no676559), eMEN (e-mental health innovation and transnational implementation platform North West Europe, H2020), EMIF (European Medical Information Framework, IMI-no115372), ERA PerMed (ERA-net Cofund in Personalized Medicine, H2020-no779282), eTRIKS (Delivering European Translational Information and Knowledge Management Services, IMI-1-no115446), EuroPOND (Data-driven models for progression of neurological diseases, H2020-n°666992), EurValve (Personalized Decision Support for Heart Valve disease, H2020-no689617), HBP SGA1/SGA2 (Human Brain Project specific grant agreements, H2020-n°720270/785907), ICT4DEPRESSION (User-friendly ICT tools to enhance self-management and effective treatment of depression in the EU, FP7-n°248778), ImpleMentAll (Towards evidence-based tailored implementation strategies for eHealth, H2020-no733025), INSTRUCT-ULTRA (Releasing the full potential of instruct to expand and consolidate infrastructure services for integrated structural life sciences research, H2020-no731005), MASTERMIND (Management of Mental Disorders through Advanced Technologies, CIP-no621000), MeDALL (Mechanisms of the Development of ALLergy, FP7-n°261357), MedBioinformatics (Creating medically-driven integrative bioinformatics applications focused on oncology, CNS disorders and their comorbidities, H2020-n°634143), MIDAS (Meaningful Integration of Data, Analytics and Services, H2020-no727721), MultipleMS (Multiple manifestations of genetic and non-genetic factors in Multiple Sclerosis disentangled with a multi-omics approach to accelerate personalized medicine, H2020-no733161), myPEBS (Randomized Comparison Of Risk-Stratified versus Standard Breast Cancer Screening European Women Aged 40–74, H2020-no755394), OpenAIRE-Advance (Advancing Open Scholarship, H2020-no777541), OpenMedicine (OpenMedicine, H2020-n°643796), PanCareSurFup (PanCare Childhood and Adolescent Cancer Survival Care and Follow-up Studies, FP7-n°257505), PIONEER (Prostate Cancer DIagnOsis and TreatmeNt Enhancement through the Power of Big Data in EuRope, H2020-IMI-2-n°777492), PREPARE (Platform for European Preparedness Against (Re-)emerging Epidemics, FP7-n°602525), Regions4PerMed (Interregional coordination for a deep and fast uptake of personalized health, H2020-no825812), RD-CONNECT (An integrated platform connecting registries, biobanks and clinical bioinformatics for rare disease research, FP7-no305344), Solve-RD (Solving the unsolved Rare Diseases, H2020-no779257), SPIDIA4P (SPIDIA for Personalized Medicine-Standardization of generic Pre-analytical procedures for In-vitro DIAgnostics for Personalized Medicine, H2020-no733112), SYSCID (A Systems medicine approach to chronic inflammatory disease, H2020-no733100), SysCLAD (Systems prediction of Chronic Allograft Dysfunction, FP7-n°305457), SYSCOL (Systems Biology of Colorectal Cancer, FP7-no258236), SysMedPD (Systems Medicine of Mitochondrial Parkinson’s Disease, H2020-n°668738), U-BIOPRED (Unbiased BIOmarkers for the PREDiction of respiratory disease outcomes, IMI-n°115010), VPH-share (Virtual Physiological Human: Sharing for Healthcare—A Research Environment, FP7-n°269978).
Repisalud
Publicación Artículo científico (JournalArticle)

Genome-wide and transcriptome-wide association studies of mammographic density phenotypes reveal novel loci

  • Chen, Hongjie
  • Fan, Shaoqi
  • Stone, Jennifer
  • Thompson, Deborah J
  • Douglas, Julie
  • Li, Shuai
  • Scott, Christopher
  • Bolla, Manjeet K
  • Wang, Qin
  • Dennis, Joe
  • Michailidou, Kyriaki
  • Li, Christopher
  • Peters, Ulrike
  • Hopper, John L
  • Southey, Melissa C
  • Nguyen-Dumont, Tu
  • Nguyen, Tuong L
  • Fasching, Peter A
  • Behrens, Annika
  • Cadby, Gemma
  • Murphy, Rachel A
  • Aronson, Kristan
  • Howell, Anthony
  • Astley, Susan
  • Couch, Fergus
  • Olson, Janet
  • Milne, Roger L
  • Giles, Graham G
  • Haiman, Christopher A
  • Maskarinec, Gertraud
  • Winham, Stacey
  • John, Esther M
  • Kurian, Allison
  • Eliassen, Heather
  • Andrulis, Irene
  • Evans, D Gareth
  • Newman, William G
  • Hall, Per
  • Czene, Kamila
  • Swerdlow, Anthony
  • Jones, Michael
  • Pollan-Santamaria, Marina
  • Fernandez-Navarro, Pablo L
  • McConnell, Daniel S
  • Kristensen, Vessela N
  • Rothstein, Joseph H
  • Wang, Pei
  • Habel, Laurel A
  • Sieh, Weiva
  • Dunning, Alison M
  • Pharoah, Paul D P
  • Easton, Douglas F
  • Gierach, Gretchen L
  • Tamimi, Rulla M
  • Vachon, Celine M
  • Lindström, Sara
Background: Mammographic density (MD) phenotypes, including percent density (PMD), area of dense tissue (DA), and area of non-dense tissue (NDA), are associated with breast cancer risk. Twin studies suggest that MD phenotypes are highly heritable. However, only a small proportion of their variance is explained by identified genetic variants. Methods: We conducted a genome-wide association study, as well as a transcriptome-wide association study (TWAS), of age- and BMI-adjusted DA, NDA, and PMD in up to 27,900 European-ancestry women from the MODE/BCAC consortia. Results: We identified 28 genome-wide significant loci for MD phenotypes, including nine novel signals (5q11.2, 5q14.1, 5q31.1, 5q33.3, 5q35.1, 7p11.2, 8q24.13, 12p11.2, 16q12.2). Further, 45% of all known breast cancer SNPs were associated with at least one MD phenotype at p < 0.05. TWAS further identified two novel genes (SHOX2 and CRISPLD2) whose genetically predicted expression was significantly associated with MD phenotypes. Conclusions: Our findings provided novel insight into the genetic background of MD phenotypes, and further demonstrated their shared genetic basis with breast cancer.
Dipòsit Digital de la UB
Publicación Artículo científico (JournalArticle)

Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer

  • Lázaro García, Conxi
  • GC-HBOC Study Collaborators
  • GEMO Study Collaborators
  • EMBRACE Collaborators
  • HEBON Investigators
  • BCFR Investigators
  • ABCTB Investigators
Genome-wide association studies (GWAS) have identified more than 170 breast cancer susceptibility loci. Here we hypothesize that some risk-associated variants might act in non-breast tissues, specifically adipose tissue and immune cells from blood and spleen. Using expression quantitative trait loci (eQTL) reported in these tissues, we identify 26 previously unreported, likely target genes of overall breast cancer risk variants, and 17 for estrogen receptor (ER)-negative breast cancer, several with a known immune function. We determine the directional effect of gene expression on disease risk measured based on single and multiple eQTL. In addition, using a gene-based test of association that considers eQTL from multiple tissues, we identify seven (and four) regions with variants associated with overall (and ER-negative) breast cancer risk, which were not reported in previous GWAS. Further investigation of the function of the implicated genes in breast and immune cells may provide insights into the etiology of breast cancer.
Dipòsit Digital de la UB
Publicación Artículo científico (JournalArticle)

Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer

  • Lázaro García, Conxi
  • ProCURE
  • Genetic Counseling Unit, Hereditary Cancer Program
Most common breast cancer susceptibility variants have been identified through genome-wide association studies (GWAS) of predominantly estrogen receptor (ER)-positive disease(1). We conducted a GWAS using 21,468 ER-negative cases and 100,594 controls combined with 18,908 BRCA1 mutation carriers (9,414 with breast cancer), all of European origin. We identified independent associations at P < 5 x 10(-8) with ten variants at nine new loci. At P < 0.05, we replicated associations with 10 of 11 variants previously reported in ER-negative disease or BRCA1 mutation carrier GWAS and observed consistent associations with ER-negative disease for 105 susceptibility variants identified by other studies. These 125 variants explain approximately 16% of the familial risk of this breast cancer subtype. There was high genetic correlation (0.72) between risk of ER-negative breast cancer and breast cancer risk for BRCA1 mutation carriers. These findings may lead to improved risk prediction and inform further fine-mapping and functional work to better understand the biological basis of ER-negative breast cancer.
Dipòsit Digital de la UB
Publicación Artículo científico (JournalArticle)

Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

  • Zhan, Haoyu
  • Ahearn, Thomas U.
  • Lecarpentier, Julie
  • Lázaro García, Conxi
  • EMBRACE Collaborators
  • GEMO Study Collaborators
Genome-wide analysis identifies 32 loci associated with breast cancer susceptibility, accounting for estrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 status and tumor grade. Breast cancer susceptibility variants frequently show heterogeneity in associations by tumor subtype(1-3). To identify novel loci, we performed a genome-wide association study including 133,384 breast cancer cases and 113,789 controls, plus 18,908 BRCA1 mutation carriers (9,414 with breast cancer) of European ancestry, using both standard and novel methodologies that account for underlying tumor heterogeneity by estrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 status and tumor grade. We identified 32 novel susceptibility loci (P < 5.0 x 10(-8)), 15 of which showed evidence for associations with at least one tumor feature (false discovery rate < 0.05). Five loci showed associations (P < 0.05) in opposite directions between luminal and non-luminal subtypes. In silico analyses showed that these five loci contained cell-specific enhancers that differed between normal luminal and basal mammary cells. The genetic correlations between five intrinsic-like subtypes ranged from 0.35 to 0.80. The proportion of genome-wide chip heritability explained by all known susceptibility loci was 54.2% for luminal A-like disease and 37.6% for triple-negative disease. The odds ratios of polygenic risk scores, which included 330 variants, for the highest 1% of quantiles compared with middle quantiles were 5.63 and 3.02 for luminal A-like and triple-negative disease, respectively. These findings provide an improved understanding of genetic predisposition to breast cancer subtypes and will inform the development of subtype-specific polygenic risk scores.
Dipòsit Digital de la UB
Publicación Artículo científico (JournalArticle)

Shared heritability and functional enrichment across six solid cancers

  • Jiang, Xia
  • Finucane, Hilary K.
  • Schumacher, Fredrick R.
  • Schmit, Stephanie L.
  • Tyrer, Jonathan P.
  • Han, Younghun
  • Michailidou, Kyriaki
  • Lesseur, Corina
  • Kuchenbaecker, Karoline B.
  • Dennis, Joe
  • Conti, David V.
  • Cunningham, Julie M.
  • John, Esther M.
  • Couch, Fergus J.
  • Bolla, Manjeet K.
  • Casey, Graham
  • Margolin, Sara
  • Goodman, Gary
  • Evans, D. Gareth
  • Riggan, Marjorie J.
  • Gago-Dominguez, Manuela
  • Jenkins, Mattias
  • Fostira, Florentia
  • Kaneva, Radka
  • Arnold, Susanne M.
  • Offit, Kenneth
  • Ruyck, Kim De
  • Olsson, Håkan
  • Arun, Banu K.
  • Schleutker, Johanna
  • Aronson, Kristan J.
  • Caligo, Maria A.
  • Tardón, Adonina
  • Edlund, Christopher K.
  • Ingles, Sue Ann
  • Hsu, Li
  • Rosenstein, Barry S.
  • Chenevix-Trench, Georgia
  • McKay, James D.
  • Claes, Kathleen B. M.
  • Chanock, Stephen J.
  • Nordestgaard, Børge G.
  • Park, Jong Y.
  • Kupryjanczyk, Jolanta
  • Cadoni, Gabriella
  • Neal, David E.
  • Diez, Orland
  • Ferris, Robert L.
  • Stefansson, Kari
  • Cannon-Albright, Lisa A.
  • Weinberg, Clarice R.
  • McGuffog, Lesley
  • Raskin, Leon
  • Mannermaa, Arto
  • Kibel, Adam S.
  • Neuhausen, Susan L.
  • Hulick, Peter J.
  • Shen, Hongbing
  • Wichmann, H-Erich
  • Goldberg, Mark S.
  • Greene, Mark H.
  • Maehle, Lovise
  • Yannoukakos, Drakoulis
  • Garber, Judy
  • Webb, Penelope M.
  • Weissler, Mark C.
  • Pejovic, Tanja
  • Bojesen, Stig E.
  • Toland, Amanda E.
  • Blomqvist, Carl
  • Knight, Julia A.
  • Huntsman, David G.
  • Dörk, Thilo
  • Gaudet, Mia M.
  • Hong, Yun-Chul
  • Whittemore, Alice S.
  • Torres, Diana
  • Hung, Rayjean J.
  • García-Closas, Montserrat
  • Li, Li
  • Friedman, Eitan
  • Hillemanns, Peter
  • Haugen, Aage
  • Cruz Correa, Marcia
  • Wolk, Alicja
  • Olopade, Olufunmilayo I.
  • Risch, Harvey A.
  • Terry, Kathryn L.
  • Hamdy, Freddie C.
  • Burwinkel, Barbara
  • Brauch, Hiltrud
  • Parsons, Michael T.
  • Tangen, Catherine M.
  • Travis, Ruth C.
  • Middha, Pooja
  • Terry, Mary Beth
  • Newcomb, Lisa F.
  • Nielsen, Finn C.
  • Ness, Andrew R.
  • Stanford, Janet L.
  • Kraft, Peter
  • Montagna, Marco
  • Brenton, James D.
  • Roobol, Monique J.
  • Thibodeau, Stephen N.
  • Sundfeldt, Karin
  • Hampe, Jochen
  • Lubiński, Jan
  • Tung, Nadine
  • Nevanlinna, Heli
  • Chang-Claude, Jenny
  • Stone, Jennifer
  • Swerdlow, Anthony J.
  • Brenner, Hermann
  • Wiklund, Fredrik
  • Bandera, Elisa V.
  • Siegel, Erin M.
  • Lester, Jenny
  • Le, Nhu D.
  • Taylor, Jack A.
  • Chan, Andrew T.
  • Donovan, Jenny L.
  • Landi, Maria Teresa
  • Aldrich, Melinda C.
  • White, Emily
  • Stevens, Victoria L.
  • Velez Edwards, Digna R.
  • Goodman, Marc T.
  • Easton, Douglas F.
  • Dwek, Miriam
  • Berchuck, Andrew
  • deFazio, Anna
  • Devilee, Peter
  • Heitz, Florian
  • Hopper, John L.
  • Hunter, David J.
  • Peters, Ulrike
  • Albanes, Jeroen R.
  • Singer, Christian F.
  • Woll, Penella
  • Tajara, Eloiza H.
  • Brunet, Joan
  • Christiani, David C.
  • Weitzel, Jeffrey N.
  • García-Sáenz, José A.
  • Liloglou, Triantafillos
  • Phipps, Amanda I.
  • Cybulski, Cezary
  • Li, Christopher I.
  • Lazarus, Philip
  • Sawyer, Elinor J.
  • Lane, Jacqueline M.
  • Meindl, Alfons
  • Liu, Geoffrey
  • Grankvist, Kjell
  • Peters, Wilbert H. M.
  • Goode, Ellen L.
  • Godwin, Andrew K.
  • Butzow, Ralf
  • Barkardottir, Rosa B.
  • Bien, Stephanie A.
  • Ulrich, Cornelia M.
  • Brunnström, Hans
  • Goldgar, David E.
  • Lee, Eunjung
  • Koutros, Stella
  • Setiawan, V. Wendy
  • Fletcher, Olivia
  • Moysich, Kirsten B.
  • Høgdall, Estrid
  • Gallinger, Steven
  • Lacko, Martin
  • Chen, Chu
  • Beckmann, Matthias W.
  • Elías Aguado-Barrera, Miguel
  • Barnes, Daniel R.
  • Imyanitov, Evgeny N.
  • Clements, Judith
  • Pandha, Hardev
  • Lenz, Heinz-Josef
  • MacInnis, Robert J.
  • Idos, Gregory
  • Daly, Mary B.
  • Anton-Culver, Hoda
  • Winqvist, Robert
  • Khusnutdinova, Elza
  • Muir, Kenneth
  • Diergaarde, Brenda
  • Collée, J. Margriet
  • Rossing, Mary Anne
  • Radice, Paolo
  • Bjørge, Line
  • Phelan, Catherine M.
  • Usmani, Nawaid
  • Brook, Mark N.
  • Rennert, Hedy S.
  • Lindo, Noralane M.
  • West, Catharine M. L.
  • Lam, Stephan
  • Teare, M. Dawn
  • Sandler, Dale P.
  • van Rensburg, Elizabeth J.
  • Levine, Douglas A.
  • Milne, Roger L.
  • Sorensen, Karina Dalsgaard
  • Sutphen, Rebecca
  • Miller, Austin
  • Isaacs, Claudine
  • Lesse, Davor
  • Zheng, Wei
  • Campbell, Peter T.
  • Olshan, Andrew F.
  • Modugno, Francesmary
  • Ramus, Susan J.
  • James, Paul
  • Cox, Angela
  • Caldés, Trinidad
  • Wang, Qin
  • Simard, Jacques
  • Schabath, Matthew B.
  • Pasaniuc, Bogdan
  • Carvalho, André L.
  • Lambrechts, Diether
  • Antonenkova, Natalia N.
  • Andrew, Angeline S.
  • Johansson, Mikael
  • Johansson, Mattias
  • Herrero, Rolando
  • Boccia, Stefania
  • Håkansson, Niclas
  • Kjaer, Susanne K.
  • Berndt, Sonja I.
  • Lejbkowicz, Flavio
  • Pharoah, Paul D. P.
  • Hamilton, Robert J.
  • Moreno Aguado, Víctor
  • Gruber, Stephen B.
  • Gronberg, Henrik
  • Kristensen, Vessela N.
  • Sieh, Weiva
  • Saxena, Richa
  • Bickeböller, Heike
  • Joshi, Amit D.
  • Olah, Edith
  • Zienolddiny, Shanbeh
  • Vega, Ana
  • Gayther, Simon A.
  • Campbell, Ian
  • Kühl, Tabea
  • Hall, Per
  • Rennert, Gad
  • Dunning, Alison M.
  • Czene, Kamila
  • Stintzing, Sebastian
  • Osorio, Ana
  • Hoffmeister, Michael
  • Spurdle, Amanda B.
  • Marchand, Loïc Le
  • Buchanan, Daniel D.
  • Slattery, Martha L.
  • Hamann, Ute
  • Caporaso, Neil E.
  • Kelemen, Linda E.
  • Mulligan, Anna Marie
  • Fortner, Renée T.
  • Weinstein, Stephanie
  • Penney, Kathryn L.
  • Mucci, Lorelei
  • Jakubowska, Anna
  • Nikitina-Zake, Liene
  • Loupakis, Fotios
  • Van Nieuwenhuysen, Els
  • Wu, Anna H.
  • Pashayan, Nora
  • Risch, Angela
  • Andrulis, Irene L.
  • Ganz, Patricia A.
  • Maier, Christiane
  • Wu, Xifeng
  • Khaw, Kay-Tee
  • Southey, Melissa C.
  • Townsend, Paul A.
  • Thomas, Duncan C.
  • Vachon, Celine M.
  • Eccles, Diana
  • Schmidt, Marjanka K.
  • Kote-Jarai, Zsofia
  • Campa, Daniele
  • Huyghe, Jeroen R.
  • Duell, Eric J.
  • Claessens, Frank
  • May, Taymaa
  • Houlston, Richard
  • Fasching, Peter A.
  • Kim, Jeri
  • Prokofyeva, Darya
  • Giles, Graham G.
  • Karlan, Beth Y.
  • Lindström, Sara
  • Antoniou, Antonis C.
  • Figueiredo, Jane C.
  • Kiemeney, Lambertus A. L. M.
  • Eeles, Rosalind A.
  • Kogevinas, Manolis
  • Bogdanova, Natalia V.
  • Guénel, Pascal
  • Gronwald, Jacek
  • Brennan, Paul
  • Batra, Jyotsna
  • Franceschi, Silvia
  • Lindblom, Annika
  • Amos, Christopher I.
  • Leslie, Goska
  • Thomassen, Mads
  • Haiman, Christopher A.
  • Nussbaum, Robert L.
  • Benlloch, Sara
  • Al Olama, Ali Amin
  • Pring, Miranda
  • Benitez, Javier
  • Ziogas, Argyrios
  • Cancel-Tassin, Géraldine
  • Price, Alkes L.
  • Woods, Michael
  • Tworoger, Shelley S.
  • Nathanson, Katherine L.
  • Ellberg, Carolina
  • Teixeira, Manuel R.
  • Saloustros, Emmanouil
  • Tischkowitz, Marc
  • Zorn, Kristin K.
  • Plaseska-Karanfilska, Dijana
  • Newcomb, Polly A.
Quantifying the genetic correlation between cancers can provide important insights into the mechanisms driving cancer etiology. Using genome-wide association study summary statistics across six cancer types based on a total of 296,215 cases and 301,319 controls of European ancestry, here we estimate the pair-wise genetic correlations between breast, colorectal, head/neck, lung, ovary and prostate cancer, and between cancers and 38 other diseases. We observed statistically significant genetic correlations between lung and head/neck cancer (rg = 0.57, p = 4.6 × 10-8), breast and ovarian cancer (rg = 0.24, p = 7 × 10-5), breast and lung cancer (rg = 0.18, p =1.5 × 10-6) and breast and colorectal cancer (rg = 0.15, p = 1.1 × 10-4). We also found that multiple cancers are genetically correlated with non-cancer traits including smoking, psychiatric diseases and metabolic characteristics. Functional enrichment analysis revealed a significant excess contribution of conserved and regulatory regions to cancer heritability. Our comprehensive analysis of cross-cancer heritability suggests that solid tumors arising across tissues share in part a common germline genetic basis.
Dipòsit Digital de la UB
Publicación Artículo científico (JournalArticle)

Transcriptome‐wide association study of breast cancer risk by estrogen‐receptor status

  • Feng, Helian
  • Gusev, Alexander
  • Pasaniuc, Bogdan
  • Lázaro García, Conxi
  • Teulé-Vega, Àlex
  • GEMO Study Collaborators
  • EMBRACE Collaborators
  • GC‐HBOC Study Collaborators
  • ABCTB Investigators
  • HEBON Investigators
  • BCFR Investigators
  • OCGN Investigators
Previous transcriptome-wide association studies (TWAS) have identified breast cancer risk genes by integrating data from expression quantitative loci and genome-wide association studies (GWAS), but analyses of breast cancer subtype-specific associations have been limited. In this study, we conducted a TWAS using gene expression data from GTEx and summary statistics from the hitherto largest GWAS meta-analysis conducted for breast cancer overall, and by estrogen receptor subtypes (ER+ and ER-). We further compared associations with ER+ and ER- subtypes, using a case-only TWAS approach. We also conducted multigene conditional analyses in regions with multiple TWAS associations. Two genes, STXBP4 and HIST2H2BA, were specifically associated with ER+ but not with ER- breast cancer. We further identified 30 TWAS-significant genes associated with overall breast cancer risk, including four that were not identified in previous studies. Conditional analyses identified single independent breast-cancer gene in three of six regions harboring multiple TWAS-significant genes. Our study provides new information on breast cancer genetics and biology, particularly about genomic differences between ER+ and ER- breast cancer.
Dipòsit Digital de la UB
Publicación Artículo científico (JournalArticle)

The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

  • Figlioli, Gisella
  • Lázaro García, Conxi
  • Pujana Genestar, M. Ángel
  • ABCTB Investigators
  • GEMO Study Collaborators
  • KConFab Investigators
Breast cancer is a common disease partially caused by genetic risk factors. Germline pathogenic variants in DNA repair genes BRCA1, BRCA2, PAM, ATM, and CHEK2 are associated with breast cancer risk. FANCM, which encodes for a DNA translocase, has been proposed as a breast cancer predisposition gene, with greater effects for the ER-negative and triple-negative breast cancer (TNBC) subtypes. We tested the three recurrent protein-truncating variants FANCM:p.Arg658*, p.Gln1701*, and pArg1931* for association with breast cancer risk in 67,112 cases, 53,766 controls, and 26,662 carriers of pathogenic variants of BRCA1 or BRCA2. These three variants were also studied functionally by measuring survival and chromosome fragility in FANCM(-/-) patient-derived immortalized fibroblasts treated with diepoxybutane or olaparib. We observed that FANCM:p.Arg658* was associated with increased risk of ER-negative disease and TNBC (OR = 2.44, P = 0.034 and OR = 3.79; P = 0.009, respectively). In a country-restricted analysis, we confirmed the associations detected for FANCM:p.Arg658* and found that also FANCM:p.Arg1931* was associated with ER-negative breast cancer risk (OR = 1.96; P = 0.006). The functional results indicated that all three variants were deleterious affecting cell survival and chromosome stability with FANCM:p.Arg658* causing more severe phenotypes. In conclusion, we confirmed that the two rare FANCM deleterious variants p.Arg658* and p.Arg1931* are risk factors for ER-negative and TNBC subtypes. Overall our data suggest that the effect of truncating variants on breast cancer risk may depend on their position in the gene. Cell sensitivity to olaparib exposure, identifies a possible therapeutic option to treat FANCM-associated tumors.
Dipòsit Digital de la UB
Publicación Artículo científico (JournalArticle)

A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

  • Pujana Genestar, M. Ángel
  • Teulé-Vega, Àlex
  • GEMO Study Collaborators
  • EMBRACE Collaborators
  • KConFab Investigators
  • HEBON Investigators
  • ABCTB Investigators
Breast cancer (BC) risk for BRCA1 and BRCA2 mutation carriers varies by genetic and familial factors. About 50 common variants have been shown to modify BC risk for mutation carriers. All but three, were identified in general population studies. Other mutation carrier-specific susceptibility variants may exist but studies of mutation carriers have so far been underpowered. We conduct a novel case-only genome-wide association study comparing genotype frequencies between 60,212 general population BC cases and 13,007 cases with BRCA1 or BRCA2 mutations. We identify robust novel associations for 2 variants with BC for BRCA1 and 3 for BRCA2 mutation carriers, P < 10-8, at 5 loci, which are not associated with risk in the general population. They include rs60882887 at 11p11.2 where MADD, SP11 and EIF1, genes previously implicated in BC biology, are predicted as potential targets. These findings will contribute towards customising BC polygenic risk scores for BRCA1 and BRCA2 mutation carriers.
Dipòsit Digital de la UB
Publicación Artículo científico (JournalArticle)

Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification

  • Parsons, Michael T.
  • Tudini, Emma
  • Li, Hongyan
  • Hahnen, Eric
  • Wappenschmidt, Barbara
  • Feliubadaló i Elorza, Maria Lídia
  • Aalfs, Cora M.
  • Agata, Simona
  • Aittomäki, Kristiina
  • Alducci, Elisa
  • Alonso Cerezo, María Concepción
  • Hauke, Jan
  • Heinrich, Tilman
  • Törngren, Therese
  • Hellebrand, Heide
  • Arnold, Norbert
  • Seggewiß, Jochen
  • Caldés, Trinidad
  • Herold, Karen N.
  • Honisch, Ellen
  • Naldi, Nadia
  • Witzel, Isabell
  • Walters, Rhiannon J.
  • Rump, Andreas
  • Horvath, Judit
  • Poplawski, Nicola K.
  • Velasco, Àngela
  • Houdayer, Claude
  • Brunet, Joan
  • Cini, Giulia
  • Hübbel, Verena
  • Iglesias, Silvia
  • Wöckel, Achim
  • Steinemann, Doris
  • Izquierdo, Angel
  • Barbieri, Elena
  • Wang Gohrke, Shan
  • James, Paul A.
  • Carnevali, Ileana
  • Torres Esquius, Sara
  • Janssen, Linda A.M.
  • Jeschke, Udo
  • Kruse, Torben A.
  • Kölbl, Alexandra
  • Ledig, Susanne
  • Cops, Elisa J.
  • Vesper, Anne Sophie
  • Kaulfuß, Silke
  • Porfirio, Berardino
  • Auber, Bernd
  • Weber, Bernhard H. F.
  • Leinert, Elena
  • Rofes, Paula
  • Bruzzone, Carla
  • Woodward, Emma R.
  • Matricardi, Laura
  • Solanes, Ares
  • Carrasco, Estela
  • Mackelenbergh, Marion T.
  • Waha, Anke
  • Nathanson, Katherine L.
  • Tucker, Katherine M.
  • Bucksch, Karolin
  • Navarro, Matilde
  • Faust, Ulrike
  • Bonanni, Bernardo
  • González, Sara
  • Nevanlinna, Heli
  • Nichols, Cassandra B.
  • Cortesi, Laura
  • Wiesmüller, Lisa
  • Niederacher, Dieter
  • Vreeswijk, Maaike P. G.
  • Caux Moncoutier, Virginie
  • Nielsen, Henriette R.
  • Giesecke, Jutta
  • Hackmann, Karl
  • Azzollini, Jacopo
  • Ong, Kai Ren
  • Pachter, Nicholas
  • Galvao, Henrique C.R.
  • Couch, Fergus J.
  • Palmero, Edenir I.
  • Guerrieri Gonzaga, Aliana
  • Cagnoli, Giulia
  • Papi, Laura
  • Asperen, Christi J.
  • Pohl Rescigno, Esther
  • Ramser, Juliane
  • Cavalli, Pietro
  • Pedersen, Inge Søkilde
  • Wagner, Sebastian A.
  • Felbor, Ute
  • Darder, Esther
  • Reis, Rui M.
  • Wieland, Kerstin
  • Gismondi, Viviana
  • Blümcke, Britta
  • Zachariae, Silke
  • Calvello, Mariarosaria
  • Stiller, Mathias
  • Bartram, Claus R.
  • Feroce, Irene
  • Stoppa-Lyonnet, Dominique
  • Keupp, Katharina
  • Hoya, Miguel
  • Lucci Cordisco, Emanuela
  • Sullivan, Kelly J.
  • Susman, Rachel
  • Zampiga, Valentina
  • Guillaud Bataille, Marine
  • Concolino, Paola
  • Sutter, Christian
  • Caliebe, Almuth
  • Gómez, Carolina
  • Tavtigian, Sean V.
  • Lewis, Alexandra L.
  • Montagna, Marco
  • Teo, Soo-Hwang
  • Teulé-Vega, Àlex
  • Debatin, Irmgard
  • Thomassen, Mads
  • Kvist, Anders
  • Gutiérrez Enríquez, Sara
  • Tibiletti, Maria Grazia
  • Meindl, Alfons
  • Fine, Miriam
  • Tischkowitz, Marc
  • Blanco, Ana
  • Toss, Angela
  • Varesco, Liliana
  • Montes, Eva
  • Garcia, Encarna B.
  • Tognazzo, Silvia
  • Caligo, Maria A.
  • Kiechle, Marion
  • Haaf, Thomas
  • Vargas Parra, Gardenía María
  • Clarke, Edward M.
  • Lim, Joanna
  • Bonache, Sandra
  • Dean, Michael
  • Michelli, Rodrigo D.
  • Gensini, Francesca
  • Gross, Eva
  • Zeder Göß, Christine
  • Gambino, Gaetana
  • Loeffler, Markus
  • Investigators, Kconfab
  • Peissel, Bernard
  • Rivera, Daniela
  • Lázaro García, Conxi
  • Nicolo, Arcangela
  • Mori, Luigi
  • Harris, Marion
  • Radice, Paolo
  • Grau Garcés, Èlia
  • Moghadasi, Setareh
  • Engel, Christoph
  • Revillion, Françoise
  • Krieger, Sophie
  • Schmutzler, Rita Katharina
  • Goldgar, David E.
  • Balmaña, Judith
  • Austin, Rachel
  • Borg, Åke
  • Salinas, Monica
  • López Fernández, Adrià
  • Spurdle, Amanda B.
  • Gehrig, Andrea
  • Capone, Gabriele L.
  • Moles Fernández, Alejandro
  • Bortesi, Beatrice
  • Grill, Sabine
  • Pérez Segura, Pedro
  • Moserle, Lidia
  • Caputo, Sandrine M.
  • Hansen, Thomas V.O.
  • Rhiem, Kerstin
  • Lattimore, Vanessa L.
  • Marabelli, Monica
  • Del Valle, Jesús
  • Lalloo, Fiona
  • Pfeifer, Katharina
  • Delnatte, Capucine
  • Toland, Amanda E.
  • Müller, Clemens R.
  • Viel, Alessandra
  • Derive, Nicolas
  • Diez, Orland
  • Sánchez de Abajo, Ana María
  • Monteiro, Alvaro N.
  • Ditsch, Nina
  • Maass, Nicolai
  • Riboli, Barbara
  • Domchek, Susan M.
  • Varon-Mateeva, Raymonda
  • Weichert, Wilko
  • Dutrannoy, Véronique
  • Eccles, Diana
  • Ehrencrona, Hans
  • Trainer, Alison H.
  • Schmidt, Gunnar
  • Enders, Ute
  • Walker, Logan C.
  • Pineda Riu, Marta
  • Evans, D. Gareth
  • Larsen, Mirjam
  • Foulkes, William D.
  • Gerdes, Anne Marie
  • Ritter, Julia
  • Farra, Chantal
  • Manoukian, Siranoush
  • Tornero, Eva
  • Schoenwiese, Ulrike
  • Germani, Aldo
  • Montalban, Gemma
  • Vega, Ana
  • Lautrup, Charlotte
  • Mundhenke, Christoph
  • Quante, Anne S.
The multifactorial likelihood analysis method has demonstrated utility for quantitative assessment of variant pathogenicity for multiple cancer syndrome genes. Independent data types currently incorporated in the model for assessing BRCA1 and BRCA2 variants include clinically calibrated prior probability of pathogenicity based on variant location and bioinformatic prediction of variant effect, co-segregation, family cancer history profile, co-occurrence with a pathogenic variant in the same gene, breast tumor pathology, and case-control information. Research and clinical data for multifactorial likelihood analysis were collated for 1,395 BRCA1/2 predominantly intronic and missense variants, enabling classification based on posterior probability of pathogenicity for 734 variants: 447 variants were classified as (likely) benign, and 94 as (likely) pathogenic; and 248 classifications were new or considerably altered relative to ClinVar submissions. Classifications were compared with information not yet included in the likelihood model, and evidence strengths aligned to those recommended for ACMG/AMP classification codes. Altered mRNA splicing or function relative to known nonpathogenic variant controls were moderately to strongly predictive of variant pathogenicity. Variant absence in population datasets provided supporting evidence for variant pathogenicity. These findings have direct relevance for BRCA1 and BRCA2 variant evaluation, and justify the need for gene-specific calibration of evidence types used for variant classification.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

  • Fachal, Laura
  • Aschard, Hugues
  • Beesley, Jonathan
  • Barnes, Daniel R.
  • Allen, Jamie
  • Kar, Siddhartha
  • Pooley, Karen A.
  • Dennis, Joe
  • Michailidou, Kyriaki
  • Turman, Constance
  • Soucy, Penny
  • Lemaçon, Audrey
  • Lush, Michael
  • Tyrer, Jonathan P.
  • Ghoussaini, Maya
  • Moradi Marjaneh, Mahdi
  • Jiang, Xia
  • Agata, Simona
  • Aittomäki, Kristiina
  • Alonso, M. Rosario
  • Andrulis, Irene L.
  • Anton-Culver, Hoda
  • Antonenkova, Natalia N.
  • Arason, Adalgeir
  • Arndt, Volker
  • Aronson, Kristan J.
  • Arun, Banu K.
  • Auber, Bernd
  • Auer, Paul L.
  • Azzollini, Jacopo
  • Balmaña, Judith
  • Barkardottir, Rosa B.
  • Barrowdale, Daniel
  • Beeghly-Fadiel, Alicia
  • Benitez, Javier
  • Bermisheva, Marina
  • Białkowska, Katarzyna
  • Blanco, Amie M.
  • Blomqvist, Carl
  • Blot, William
  • Bogdanova, Natalia V.
  • Bojesen, Stig E.
  • Bolla, Manjeet K.
  • Bonanni, Bernardo
  • Borg, Ake
  • Bosse, Kristin
  • Brauch, Hiltrud
  • Brenner, H.
  • Briceno, I.
  • Caldés, T.
  • Castelao, J. E.
  • Hoya, Miguel de la
  • Diez, Orland
  • Durán, Mercedes
  • Gago-Dominguez, Manuela
  • García-Saenz, José Ángel
  • González-Neira, Anna
  • Moreno, Fernando
  • Muñoz-Garzón, Víctor M.
  • Osorio, Ana
  • Pujana, Miguel Ángel
  • Romero, Atocha
  • Sánchez-Herrero, Estela
  • Santamariña, Marta
  • Teulé, Alex
  • Vega, Ana I.
Genome-wide association studies have identified breast cancer risk variants in over 150 genomic regions, but the mechanisms underlying risk remain largely unknown. These regions were explored by combining association analysis with in silico genomic feature annotations. We defined 205 independent risk-associated signals with the set of credible causal variants in each one. In parallel, we used a Bayesian approach (PAINTOR) that combines genetic association, linkage disequilibrium and enriched genomic features to determine variants with high posterior probabilities of being causal. Potentially causal variants were significantly over-represented in active gene regulatory regions and transcription factor binding sites. We applied our INQUSIT pipeline for prioritizing genes as targets of those potentially causal variants, using gene expression (expression quantitative trait loci), chromatin interaction and functional annotations. Known cancer drivers, transcription factors and genes in the developmental, apoptosis, immune system and DNA integrity checkpoint gene ontology pathways were over-represented among the highest-confidence target genes., This work was supported by the European Union’s Horizon 2020 Research and Innovation Programme under Marie Sklodowska-Curie grant agreement number 656144. Genotyping of the OncoArray was principally funded from three sources: the PERSPECTIVE project (funded by the Government of Canada through Genome Canada and the Canadian Institutes of Health Research, the ‘Ministère de l’Économie de la Science et de l’Innovation du Québec’ (through Genome Québec) and the Quebec Breast Cancer Foundation); the NCI Genetic Associations and Mechanisms in Oncology (GAME-ON) initiative and the Discovery, Biology and Risk of Inherited Variants in Breast Cancer (DRIVE) project (NIH grants U19 CA148065 and X01HG007492); and Cancer Research UK (C1287/A10118, C8197/A16565 and C1287/A16563). BCAC is funded by Cancer Research UK (C1287/A16563), by the European Community’s Seventh Framework Programme under grant agreement 223175 (HEALTH-F2-2009-223175) (COGS) and by the European Union’s Horizon 2020 Research and Innovation Programme under grant agreements 633784 (B-CAST) and 634935 (BRIDGES). Genotyping of the iCOGS array was funded by the European Union (HEALTH-F2-2009-223175), Cancer Research UK (C1287/A10710), the Canadian Institutes of Health Research for the ‘CIHR Team in Familial Risks of Breast Cancer’ program, and the Ministry of Economic Development, Innovation and Export Trade of Quebec (grant PSR-SIIRI-701). Combining of the GWAS data was supported in part by NIH Cancer Post-Cancer GWAS initiative grant U19 CA 148065 (DRIVE; part of the GAME-ON initiative).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Towards a European health research and innovation cloud (HRIC)

  • Aarestrup, Frank M.
  • Gut, Ivo Glynne
  • Sanz, Ferran
  • Van Oyen, Herman
The European Union (EU) initiative on the Digital Transformation of Health and Care (Digicare) aims to provide the conditions necessary for building a secure, flexible, and decentralized digital health infrastructure. Creating a European Health Research and Innovation Cloud (HRIC) within this environment should enable data sharing and analysis for health research across the EU, in compliance with data protection legislation while preserving the full trust of the participants. Such a HRIC should learn from and build on existing data infrastructures, integrate best practices, and focus on the concrete needs of the community in terms of technologies, governance, management, regulation, and ethics requirements. Here, we describe the vision and expected benefits of digital data sharing in health research activities and present a roadmap that fosters the opportunities while answering the challenges of implementing a HRIC. For this, we put forward five specific recommendations and action points to ensure that a European HRIC: i) is built on established standards and guidelines, providing cloud technologies through an open and decentralized infrastructure; ii) is developed and certified to the highest standards of interoperability and data security that can be trusted by all stakeholders; iii) is supported by a robust ethical and legal framework that is compliant with the EU General Data Protection Regulation (GDPR); iv) establishes a proper environment for the training of new generations of data and medical scientists; and v) stimulates research and innovation in transnational collaborations through public and private initiatives and partnerships funded by the EU through Horizon 2020 and Horizon Europe., The workshop participants received funding from the European Union Seventh Program for Research, Technological Development and Demonstration (FP7) and Horizon Research and Innovation Program (H2020) and other European Union programs under the following grant agreements: AETIONOMY (Developing an Aetiology-based Taxonomy of Human Disease—Approaches to Develop a New Taxonomy for Neurological Disorders, IMI-no115568), ANTI-SUPERBUG PCP (ANTISUPERBUG Precommercial Procurement, H2020-no688878), B-CAST (Breast CAncer Stratification understanding the determinants of risk and prognosis of molecular sub-types, H2020-no633784), BRIDGE Health (Bridging information and data generation for evidence-based health policy and research, H2020-no664691), CASyM (Coordinating Action Systems Medicine—Implementation of Systems Medicine across Europe, FP7-n°305033), CENTER-TBI (Collaborative European NeuroTrauma Effectiveness Research in TBI, FP7-no602150), CECM (Centre for New Methods in Computational Diagnostics and Personalized Therapy, H2020-no763734), COLOSSUS (Advancing a Precision Medicine Paradigm in Metastatic Colorectal Cancer: Systems based patient stratification solutions, H2020-no754923), COMPARE (COllaborative Management Platform for detection and Analyses of (Re-)emerging and foodborne outbreaks in Europe, H2020-no643476), CONNECARE (Personalized Connected Care for Complex Chronic Patients, H2020-no689802), CREATIVE (Collaborative REsearch on ACute Traumatic brain Injury in intensiVe care medicine in Europe, FP7-no602714), DEFORM (Define the global and financial impact of research misconduct H2020-no710246), ECCTR (European Cornea and Cell Transplant Registry, FP7-n°709723), E-COMPARED (European COMPARative Effectiveness Research on online Depression, FP7-no603098), ECRIN-IA (European Clinical Research Infrastructures Network- Integrating Activity, FP7-no284395), EHR4CR (Electronic Health Records Systems for Clinical Research, IMI-no115189) eInfraCentral (European E-infrastructures Services Gateway, H2020-no731049), ELIXIR (European Life-science Infrastructure for Biological Information, FP7-n°211601), ELIXIR-EXCELERATE (Fast track ELIXIR implementation and drive early user exploitation across the life sciences, H2020-no676559), eMEN (e-mental health innovation and transnational implementation platform North West Europe, H2020), EMIF (European Medical Information Framework, IMI-no115372), ERA PerMed (ERA-net Cofund in Personalized Medicine, H2020-no779282), eTRIKS (Delivering European Translational Information and Knowledge Management Services, IMI-1-no115446), EuroPOND (Data-driven models for progression of neurological diseases, H2020-n°666992), EurValve (Personalized Decision Support for Heart Valve disease, H2020-no689617), HBP SGA1/SGA2 (Human Brain Project specific grant agreements, H2020-n°720270/785907), ICT4DEPRESSION (User-friendly ICT tools to enhance self-management and effective treatment of depression in the EU, FP7-n°248778), ImpleMentAll (Towards evidence-based tailored implementation strategies for eHealth, H2020-no733025), INSTRUCT-ULTRA (Releasing the full potential of instruct to expand and consolidate infrastructure services for integrated structural life sciences research, H2020-no731005), MASTERMIND (Management of Mental Disorders through Advanced Technologies, CIP-no621000), MeDALL (Mechanisms of the Development of ALLergy, FP7-n°261357), MedBioinformatics (Creating medically-driven integrative bioinformatics applications focused on oncology, CNS disorders and their comorbidities, H2020-n°634143), MIDAS (Meaningful Integration of Data, Analytics and Services, H2020-no727721), MultipleMS (Multiple manifestations of genetic and non-genetic factors in Multiple Sclerosis disentangled with a multi-omics approach to accelerate personalized medicine, H2020-no733161), myPEBS (Randomized Comparison Of Risk-Stratified versus Standard Breast Cancer Screening European Women Aged 40–74, H2020-no755394), OpenAIRE-Advance (Advancing Open Scholarship, H2020-no777541), OpenMedicine (OpenMedicine, H2020-n°643796), PanCareSurFup (PanCare Childhood and Adolescent Cancer Survival Care and Follow-up Studies, FP7-n°257505), PIONEER (Prostate Cancer DIagnOsis and TreatmeNt Enhancement through the Power of Big Data in EuRope, H2020-IMI-2-n°777492), PREPARE (Platform for European Preparedness Against (Re-)emerging Epidemics, FP7-n°602525), Regions4PerMed (Interregional coordination for a deep and fast uptake of personalized health, H2020-no825812), RD-CONNECT (An integrated platform connecting registries, biobanks and clinical bioinformatics for rare disease research, FP7-no305344), Solve-RD (Solving the unsolved Rare Diseases, H2020-no779257), SPIDIA4P (SPIDIA for Personalized Medicine-Standardization of generic Pre-analytical procedures for In-vitro DIAgnostics for Personalized Medicine, H2020-no733112), SYSCID (A Systems medicine approach to chronic inflammatory disease, H2020-no733100), SysCLAD (Systems prediction of Chronic Allograft Dysfunction, FP7-n°305457), SYSCOL (Systems Biology of Colorectal Cancer, FP7-no258236), SysMedPD (Systems Medicine of Mitochondrial Parkinson’s Disease, H2020-n°668738), U-BIOPRED (Unbiased BIOmarkers for the PREDiction of respiratory disease outcomes, IMI-n°115010), VPH-share (Virtual Physiological Human: Sharing for Healthcare—A Research Environment, FP7-n°269978).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

  • Figlioli, Gisella
  • Lázaro García, Conxi
  • Pujana Genestar, M. Ángel
  • ABCTB Investigators
  • GEMO Study Collaborators
  • KConFab Investigators
Breast cancer is a common disease partially caused by genetic risk factors. Germline pathogenic variants in DNA repair genes BRCA1, BRCA2, PAM, ATM, and CHEK2 are associated with breast cancer risk. FANCM, which encodes for a DNA translocase, has been proposed as a breast cancer predisposition gene, with greater effects for the ER-negative and triple-negative breast cancer (TNBC) subtypes. We tested the three recurrent protein-truncating variants FANCM:p.Arg658*, p.Gln1701*, and pArg1931* for association with breast cancer risk in 67,112 cases, 53,766 controls, and 26,662 carriers of pathogenic variants of BRCA1 or BRCA2. These three variants were also studied functionally by measuring survival and chromosome fragility in FANCM(-/-) patient-derived immortalized fibroblasts treated with diepoxybutane or olaparib. We observed that FANCM:p.Arg658* was associated with increased risk of ER-negative disease and TNBC (OR = 2.44, P = 0.034 and OR = 3.79; P = 0.009, respectively). In a country-restricted analysis, we confirmed the associations detected for FANCM:p.Arg658* and found that also FANCM:p.Arg1931* was associated with ER-negative breast cancer risk (OR = 1.96; P = 0.006). The functional results indicated that all three variants were deleterious affecting cell survival and chromosome stability with FANCM:p.Arg658* causing more severe phenotypes. In conclusion, we confirmed that the two rare FANCM deleterious variants p.Arg658* and p.Arg1931* are risk factors for ER-negative and TNBC subtypes. Overall our data suggest that the effect of truncating variants on breast cancer risk may depend on their position in the gene. Cell sensitivity to olaparib exposure, identifies a possible therapeutic option to treat FANCM-associated tumors.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Transcriptome‐wide association study of breast cancer risk by estrogen‐receptor status

  • Feng, Helian
  • Gusev, Alexander
  • Pasaniuc, Bogdan
  • Lázaro García, Conxi
  • Teulé-Vega, Àlex
  • GEMO Study Collaborators
  • EMBRACE Collaborators
  • GC‐HBOC Study Collaborators
  • ABCTB Investigators
  • HEBON Investigators
  • BCFR Investigators
  • OCGN Investigators
Previous transcriptome-wide association studies (TWAS) have identified breast cancer risk genes by integrating data from expression quantitative loci and genome-wide association studies (GWAS), but analyses of breast cancer subtype-specific associations have been limited. In this study, we conducted a TWAS using gene expression data from GTEx and summary statistics from the hitherto largest GWAS meta-analysis conducted for breast cancer overall, and by estrogen receptor subtypes (ER+ and ER-). We further compared associations with ER+ and ER- subtypes, using a case-only TWAS approach. We also conducted multigene conditional analyses in regions with multiple TWAS associations. Two genes, STXBP4 and HIST2H2BA, were specifically associated with ER+ but not with ER- breast cancer. We further identified 30 TWAS-significant genes associated with overall breast cancer risk, including four that were not identified in previous studies. Conditional analyses identified single independent breast-cancer gene in three of six regions harboring multiple TWAS-significant genes. Our study provides new information on breast cancer genetics and biology, particularly about genomic differences between ER+ and ER- breast cancer.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Shared heritability and functional enrichment across six solid cancers

  • Jiang, Xia
  • Finucane, Hilary K.
  • Schumacher, Fredrick R.
  • Schmit, Stephanie L.
  • Tyrer, Jonathan P.
  • Han, Younghun
  • Michailidou, Kyriaki
  • Lesseur, Corina
  • Kuchenbaecker, Karoline B.
  • Dennis, Joe
  • Conti, David V.
  • Cunningham, Julie M.
  • John, Esther M.
  • Couch, Fergus J.
  • Bolla, Manjeet K.
  • Casey, Graham
  • Margolin, Sara
  • Goodman, Gary
  • Evans, D. Gareth
  • Riggan, Marjorie J.
  • Gago-Dominguez, Manuela
  • Jenkins, Mattias
  • Fostira, Florentia
  • Kaneva, Radka
  • Arnold, Susanne M.
  • Offit, Kenneth
  • Ruyck, Kim De
  • Olsson, Håkan
  • Arun, Banu K.
  • Schleutker, Johanna
  • Aronson, Kristan J.
  • Caligo, Maria A.
  • Tardón, Adonina
  • Edlund, Christopher K.
  • Ingles, Sue Ann
  • Hsu, Li
  • Rosenstein, Barry S.
  • Chenevix-Trench, Georgia
  • McKay, James D.
  • Claes, Kathleen B. M.
  • Chanock, Stephen J.
  • Nordestgaard, Børge G.
  • Park, Jong Y.
  • Kupryjanczyk, Jolanta
  • Cadoni, Gabriella
  • Neal, David E.
  • Diez, Orland
  • Ferris, Robert L.
  • Stefansson, Kari
  • Cannon-Albright, Lisa A.
  • Weinberg, Clarice R.
  • McGuffog, Lesley
  • Raskin, Leon
  • Mannermaa, Arto
  • Kibel, Adam S.
  • Neuhausen, Susan L.
  • Hulick, Peter J.
  • Shen, Hongbing
  • Wichmann, H-Erich
  • Goldberg, Mark S.
  • Greene, Mark H.
  • Maehle, Lovise
  • Yannoukakos, Drakoulis
  • Garber, Judy
  • Webb, Penelope M.
  • Weissler, Mark C.
  • Pejovic, Tanja
  • Bojesen, Stig E.
  • Toland, Amanda E.
  • Blomqvist, Carl
  • Knight, Julia A.
  • Huntsman, David G.
  • Dörk, Thilo
  • Gaudet, Mia M.
  • Hong, Yun-Chul
  • Whittemore, Alice S.
  • Torres, Diana
  • Hung, Rayjean J.
  • García-Closas, Montserrat
  • Li, Li
  • Friedman, Eitan
  • Hillemanns, Peter
  • Haugen, Aage
  • Cruz Correa, Marcia
  • Wolk, Alicja
  • Olopade, Olufunmilayo I.
  • Risch, Harvey A.
  • Terry, Kathryn L.
  • Hamdy, Freddie C.
  • Burwinkel, Barbara
  • Brauch, Hiltrud
  • Parsons, Michael T.
  • Tangen, Catherine M.
  • Travis, Ruth C.
  • Middha, Pooja
  • Terry, Mary Beth
  • Newcomb, Lisa F.
  • Nielsen, Finn C.
  • Ness, Andrew R.
  • Stanford, Janet L.
  • Kraft, Peter
  • Montagna, Marco
  • Brenton, James D.
  • Roobol, Monique J.
  • Thibodeau, Stephen N.
  • Sundfeldt, Karin
  • Hampe, Jochen
  • Lubiński, Jan
  • Tung, Nadine
  • Nevanlinna, Heli
  • Chang-Claude, Jenny
  • Stone, Jennifer
  • Swerdlow, Anthony J.
  • Brenner, Hermann
  • Wiklund, Fredrik
  • Bandera, Elisa V.
  • Siegel, Erin M.
  • Lester, Jenny
  • Le, Nhu D.
  • Taylor, Jack A.
  • Chan, Andrew T.
  • Donovan, Jenny L.
  • Landi, Maria Teresa
  • Aldrich, Melinda C.
  • White, Emily
  • Stevens, Victoria L.
  • Velez Edwards, Digna R.
  • Goodman, Marc T.
  • Easton, Douglas F.
  • Dwek, Miriam
  • Berchuck, Andrew
  • deFazio, Anna
  • Devilee, Peter
  • Heitz, Florian
  • Hopper, John L.
  • Hunter, David J.
  • Peters, Ulrike
  • Albanes, Jeroen R.
  • Singer, Christian F.
  • Woll, Penella
  • Tajara, Eloiza H.
  • Brunet, Joan
  • Christiani, David C.
  • Weitzel, Jeffrey N.
  • García-Sáenz, José A.
  • Liloglou, Triantafillos
  • Phipps, Amanda I.
  • Cybulski, Cezary
  • Li, Christopher I.
  • Lazarus, Philip
  • Sawyer, Elinor J.
  • Lane, Jacqueline M.
  • Meindl, Alfons
  • Liu, Geoffrey
  • Grankvist, Kjell
  • Peters, Wilbert H. M.
  • Goode, Ellen L.
  • Godwin, Andrew K.
  • Butzow, Ralf
  • Barkardottir, Rosa B.
  • Bien, Stephanie A.
  • Ulrich, Cornelia M.
  • Brunnström, Hans
  • Goldgar, David E.
  • Lee, Eunjung
  • Koutros, Stella
  • Setiawan, V. Wendy
  • Fletcher, Olivia
  • Moysich, Kirsten B.
  • Høgdall, Estrid
  • Gallinger, Steven
  • Lacko, Martin
  • Chen, Chu
  • Beckmann, Matthias W.
  • Elías Aguado-Barrera, Miguel
  • Barnes, Daniel R.
  • Imyanitov, Evgeny N.
  • Clements, Judith
  • Pandha, Hardev
  • Lenz, Heinz-Josef
  • MacInnis, Robert J.
  • Idos, Gregory
  • Daly, Mary B.
  • Anton-Culver, Hoda
  • Winqvist, Robert
  • Khusnutdinova, Elza
  • Muir, Kenneth
  • Diergaarde, Brenda
  • Collée, J. Margriet
  • Rossing, Mary Anne
  • Radice, Paolo
  • Bjørge, Line
  • Phelan, Catherine M.
  • Usmani, Nawaid
  • Brook, Mark N.
  • Rennert, Hedy S.
  • Lindo, Noralane M.
  • West, Catharine M. L.
  • Lam, Stephan
  • Teare, M. Dawn
  • Sandler, Dale P.
  • van Rensburg, Elizabeth J.
  • Levine, Douglas A.
  • Milne, Roger L.
  • Sorensen, Karina Dalsgaard
  • Sutphen, Rebecca
  • Miller, Austin
  • Isaacs, Claudine
  • Lesse, Davor
  • Zheng, Wei
  • Campbell, Peter T.
  • Olshan, Andrew F.
  • Modugno, Francesmary
  • Ramus, Susan J.
  • James, Paul
  • Cox, Angela
  • Caldés, Trinidad
  • Wang, Qin
  • Simard, Jacques
  • Schabath, Matthew B.
  • Pasaniuc, Bogdan
  • Carvalho, André L.
  • Lambrechts, Diether
  • Antonenkova, Natalia N.
  • Andrew, Angeline S.
  • Johansson, Mikael
  • Johansson, Mattias
  • Herrero, Rolando
  • Boccia, Stefania
  • Håkansson, Niclas
  • Kjaer, Susanne K.
  • Berndt, Sonja I.
  • Lejbkowicz, Flavio
  • Pharoah, Paul D. P.
  • Hamilton, Robert J.
  • Moreno Aguado, Víctor
  • Gruber, Stephen B.
  • Gronberg, Henrik
  • Kristensen, Vessela N.
  • Sieh, Weiva
  • Saxena, Richa
  • Bickeböller, Heike
  • Joshi, Amit D.
  • Olah, Edith
  • Zienolddiny, Shanbeh
  • Vega, Ana
  • Gayther, Simon A.
  • Campbell, Ian
  • Kühl, Tabea
  • Hall, Per
  • Rennert, Gad
  • Dunning, Alison M.
  • Czene, Kamila
  • Stintzing, Sebastian
  • Osorio, Ana
  • Hoffmeister, Michael
  • Spurdle, Amanda B.
  • Marchand, Loïc Le
  • Buchanan, Daniel D.
  • Slattery, Martha L.
  • Hamann, Ute
  • Caporaso, Neil E.
  • Kelemen, Linda E.
  • Mulligan, Anna Marie
  • Fortner, Renée T.
  • Weinstein, Stephanie
  • Penney, Kathryn L.
  • Mucci, Lorelei
  • Jakubowska, Anna
  • Nikitina-Zake, Liene
  • Loupakis, Fotios
  • Van Nieuwenhuysen, Els
  • Wu, Anna H.
  • Pashayan, Nora
  • Risch, Angela
  • Andrulis, Irene L.
  • Ganz, Patricia A.
  • Maier, Christiane
  • Wu, Xifeng
  • Khaw, Kay-Tee
  • Southey, Melissa C.
  • Townsend, Paul A.
  • Thomas, Duncan C.
  • Vachon, Celine M.
  • Eccles, Diana
  • Schmidt, Marjanka K.
  • Kote-Jarai, Zsofia
  • Campa, Daniele
  • Huyghe, Jeroen R.
  • Duell, Eric J.
  • Claessens, Frank
  • May, Taymaa
  • Houlston, Richard
  • Fasching, Peter A.
  • Kim, Jeri
  • Prokofyeva, Darya
  • Giles, Graham G.
  • Karlan, Beth Y.
  • Lindström, Sara
  • Antoniou, Antonis C.
  • Figueiredo, Jane C.
  • Kiemeney, Lambertus A. L. M.
  • Eeles, Rosalind A.
  • Kogevinas, Manolis
  • Bogdanova, Natalia V.
  • Guénel, Pascal
  • Gronwald, Jacek
  • Brennan, Paul
  • Batra, Jyotsna
  • Franceschi, Silvia
  • Lindblom, Annika
  • Amos, Christopher I.
  • Leslie, Goska
  • Thomassen, Mads
  • Haiman, Christopher A.
  • Nussbaum, Robert L.
  • Benlloch, Sara
  • Al Olama, Ali Amin
  • Pring, Miranda
  • Benitez, Javier
  • Ziogas, Argyrios
  • Cancel-Tassin, Géraldine
  • Price, Alkes L.
  • Woods, Michael
  • Tworoger, Shelley S.
  • Nathanson, Katherine L.
  • Ellberg, Carolina
  • Teixeira, Manuel R.
  • Saloustros, Emmanouil
  • Tischkowitz, Marc
  • Zorn, Kristin K.
  • Plaseska-Karanfilska, Dijana
  • Newcomb, Polly A.
Quantifying the genetic correlation between cancers can provide important insights into the mechanisms driving cancer etiology. Using genome-wide association study summary statistics across six cancer types based on a total of 296,215 cases and 301,319 controls of European ancestry, here we estimate the pair-wise genetic correlations between breast, colorectal, head/neck, lung, ovary and prostate cancer, and between cancers and 38 other diseases. We observed statistically significant genetic correlations between lung and head/neck cancer (rg = 0.57, p = 4.6 × 10-8), breast and ovarian cancer (rg = 0.24, p = 7 × 10-5), breast and lung cancer (rg = 0.18, p =1.5 × 10-6) and breast and colorectal cancer (rg = 0.15, p = 1.1 × 10-4). We also found that multiple cancers are genetically correlated with non-cancer traits including smoking, psychiatric diseases and metabolic characteristics. Functional enrichment analysis revealed a significant excess contribution of conserved and regulatory regions to cancer heritability. Our comprehensive analysis of cross-cancer heritability suggests that solid tumors arising across tissues share in part a common germline genetic basis.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification

  • Parsons, Michael T.
  • Tudini, Emma
  • Li, Hongyan
  • Hahnen, Eric
  • Wappenschmidt, Barbara
  • Feliubadaló i Elorza, Maria Lídia
  • Aalfs, Cora M.
  • Agata, Simona
  • Aittomäki, Kristiina
  • Alducci, Elisa
  • Alonso Cerezo, María Concepción
  • Hauke, Jan
  • Heinrich, Tilman
  • Törngren, Therese
  • Hellebrand, Heide
  • Arnold, Norbert
  • Seggewiß, Jochen
  • Caldés, Trinidad
  • Herold, Karen N.
  • Honisch, Ellen
  • Naldi, Nadia
  • Witzel, Isabell
  • Walters, Rhiannon J.
  • Rump, Andreas
  • Horvath, Judit
  • Poplawski, Nicola K.
  • Velasco, Àngela
  • Houdayer, Claude
  • Brunet, Joan
  • Cini, Giulia
  • Hübbel, Verena
  • Iglesias, Silvia
  • Wöckel, Achim
  • Steinemann, Doris
  • Izquierdo, Angel
  • Barbieri, Elena
  • Wang Gohrke, Shan
  • James, Paul A.
  • Carnevali, Ileana
  • Torres Esquius, Sara
  • Janssen, Linda A.M.
  • Jeschke, Udo
  • Kruse, Torben A.
  • Kölbl, Alexandra
  • Ledig, Susanne
  • Cops, Elisa J.
  • Vesper, Anne Sophie
  • Kaulfuß, Silke
  • Porfirio, Berardino
  • Auber, Bernd
  • Weber, Bernhard H. F.
  • Leinert, Elena
  • Rofes, Paula
  • Bruzzone, Carla
  • Woodward, Emma R.
  • Matricardi, Laura
  • Solanes, Ares
  • Carrasco, Estela
  • Mackelenbergh, Marion T.
  • Waha, Anke
  • Nathanson, Katherine L.
  • Tucker, Katherine M.
  • Bucksch, Karolin
  • Navarro, Matilde
  • Faust, Ulrike
  • Bonanni, Bernardo
  • González, Sara
  • Nevanlinna, Heli
  • Nichols, Cassandra B.
  • Cortesi, Laura
  • Wiesmüller, Lisa
  • Niederacher, Dieter
  • Vreeswijk, Maaike P. G.
  • Caux Moncoutier, Virginie
  • Nielsen, Henriette R.
  • Giesecke, Jutta
  • Hackmann, Karl
  • Azzollini, Jacopo
  • Ong, Kai Ren
  • Pachter, Nicholas
  • Galvao, Henrique C.R.
  • Couch, Fergus J.
  • Palmero, Edenir I.
  • Guerrieri Gonzaga, Aliana
  • Cagnoli, Giulia
  • Papi, Laura
  • Asperen, Christi J.
  • Pohl Rescigno, Esther
  • Ramser, Juliane
  • Cavalli, Pietro
  • Pedersen, Inge Søkilde
  • Wagner, Sebastian A.
  • Felbor, Ute
  • Darder, Esther
  • Reis, Rui M.
  • Wieland, Kerstin
  • Gismondi, Viviana
  • Blümcke, Britta
  • Zachariae, Silke
  • Calvello, Mariarosaria
  • Stiller, Mathias
  • Bartram, Claus R.
  • Feroce, Irene
  • Stoppa-Lyonnet, Dominique
  • Keupp, Katharina
  • Hoya, Miguel
  • Lucci Cordisco, Emanuela
  • Sullivan, Kelly J.
  • Susman, Rachel
  • Zampiga, Valentina
  • Guillaud Bataille, Marine
  • Concolino, Paola
  • Sutter, Christian
  • Caliebe, Almuth
  • Gómez, Carolina
  • Tavtigian, Sean V.
  • Lewis, Alexandra L.
  • Montagna, Marco
  • Teo, Soo H.
  • Teulé, Alex
  • Debatin, Irmgard
  • Thomassen, Mads
  • Kvist, Anders
  • Gutiérrez Enríquez, Sara
  • Tibiletti, Maria Grazia
  • Meindl, Alfons
  • Fine, Miriam
  • Tischkowitz, Marc
  • Blanco, Ana
  • Toss, Angela
  • Varesco, Liliana
  • Montes, Eva
  • Garcia, Encarna B.
  • Tognazzo, Silvia
  • Caligo, Maria A.
  • Kiechle, Marion
  • Haaf, Thomas
  • Vargas Parra, Gardenía María
  • Clarke, Edward M.
  • Lim, Joanna
  • Bonache, Sandra
  • Dean, Michael
  • Michelli, Rodrigo D.
  • Gensini, Francesca
  • Gross, Eva
  • Zeder Göß, Christine
  • Gambino, Gaetana
  • Loeffler, Markus
  • Investigators, Kconfab
  • Peissel, Bernard
  • Rivera, Daniela
  • Lázaro García, Conxi
  • Nicolo, Arcangela
  • Mori, Luigi
  • Harris, Marion
  • Radice, Paolo
  • Grau Garcés, Èlia
  • Moghadasi, Setareh
  • Engel, Christoph
  • Revillion, Françoise
  • Krieger, Sophie
  • Schmutzler, Rita Katharina
  • Goldgar, David E.
  • Balmaña, Judith
  • Austin, Rachel
  • Borg, Åke
  • Salinas, Monica
  • López Fernández, Adrià
  • Spurdle, Amanda B.
  • Gehrig, Andrea
  • Capone, Gabriele L.
  • Moles Fernández, Alejandro
  • Bortesi, Beatrice
  • Grill, Sabine
  • Pérez Segura, Pedro
  • Moserle, Lidia
  • Caputo, Sandrine M.
  • Hansen, Thomas V.O.
  • Rhiem, Kerstin
  • Lattimore, Vanessa L.
  • Marabelli, Monica
  • Del Valle, Jesús
  • Lalloo, Fiona
  • Pfeifer, Katharina
  • Delnatte, Capucine
  • Toland, Amanda E.
  • Müller, Clemens R.
  • Viel, Alessandra
  • Derive, Nicolas
  • Diez, Orland
  • Sánchez de Abajo, Ana María
  • Monteiro, Alvaro N.
  • Ditsch, Nina
  • Maass, Nicolai
  • Riboli, Barbara
  • Domchek, Susan M.
  • Varon-Mateeva, Raymonda
  • Weichert, Wilko
  • Dutrannoy, Véronique
  • Eccles, Diana
  • Ehrencrona, Hans
  • Trainer, Alison H.
  • Schmidt, Gunnar
  • Enders, Ute
  • Walker, Logan C.
  • Pineda Riu, Marta
  • Evans, D. Gareth
  • Larsen, Mirjam
  • Foulkes, William D.
  • Gerdes, Anne Marie
  • Ritter, Julia
  • Farra, Chantal
  • Manoukian, Siranoush
  • Tornero, Eva
  • Schoenwiese, Ulrike
  • Germani, Aldo
  • Montalban, Gemma
  • Vega, Ana
  • Lautrup, Charlotte
  • Mundhenke, Christoph
  • Quante, Anne S.
The multifactorial likelihood analysis method has demonstrated utility for quantitative assessment of variant pathogenicity for multiple cancer syndrome genes. Independent data types currently incorporated in the model for assessing BRCA1 and BRCA2 variants include clinically calibrated prior probability of pathogenicity based on variant location and bioinformatic prediction of variant effect, co-segregation, family cancer history profile, co-occurrence with a pathogenic variant in the same gene, breast tumor pathology, and case-control information. Research and clinical data for multifactorial likelihood analysis were collated for 1,395 BRCA1/2 predominantly intronic and missense variants, enabling classification based on posterior probability of pathogenicity for 734 variants: 447 variants were classified as (likely) benign, and 94 as (likely) pathogenic; and 248 classifications were new or considerably altered relative to ClinVar submissions. Classifications were compared with information not yet included in the likelihood model, and evidence strengths aligned to those recommended for ACMG/AMP classification codes. Altered mRNA splicing or function relative to known nonpathogenic variant controls were moderately to strongly predictive of variant pathogenicity. Variant absence in population datasets provided supporting evidence for variant pathogenicity. These findings have direct relevance for BRCA1 and BRCA2 variant evaluation, and justify the need for gene-specific calibration of evidence types used for variant classification.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Incorporating Alternative Polygenic Risk Scores into the BOADICEA Breast Cancer Risk Prediction Model

  • Mavaddat, Nasim
  • Ficorella, Lorenzo
  • Carver, Tim
  • Lee, Andrew
  • Cunningham, Alex P.
  • Pardo Muñoz, Monica
  • Balmaña Gelpí, Judith
  • Lush, Michael
Polygenic risk; Prediction; Breast cancer, Riesgo poligénico; Predicción; Cáncer de mama, Risc poligènic; Predicció; Càncer de mama, Background: The multifactorial risk prediction model BOADICEA enables identification of women at higher or lower risk of developing breast cancer. BOADICEA models genetic susceptibility in terms of the effects of rare variants in breast cancer susceptibility genes and a polygenic component, decomposed into an unmeasured and a measured component - the polygenic risk score (PRS). The current version was developed using a 313 SNP PRS. Here, we evaluated approaches to incorporating this PRS and alternative PRS in BOADICEA. Methods: The mean, SD, and proportion of the overall polygenic component explained by the PRS (α2) need to be estimated. α was estimated using logistic regression, where the age-specific log-OR is constrained to be a function of the age-dependent polygenic relative risk in BOADICEA; and using a retrospective likelihood (RL) approach that models, in addition, the unmeasured polygenic component. Results: Parameters were computed for 11 PRS, including 6 variations of the 313 SNP PRS used in clinical trials and implementation studies. The logistic regression approach underestimates α⁠, as compared with the RL estimates. The RL α estimates were very close to those obtained by assuming proportionality to the OR per 1 SD, with the constant of proportionality estimated using the 313 SNP PRS. Small variations in the SNPs included in the PRS can lead to large differences in the mean. Conclusions: BOADICEA can be readily adapted to different PRS in a manner that maintains consistency of the model., This work has been supported by grants from Cancer Research UK (PPRPGM-Nov20\100002); the European Union's Horizon 2020 Research and Innovation Programme under grant agreement numbers 633784 (B-CAST) and 634935 (BRIDGES); the PERSPECTIVE I&I project which is funded by the Government of Canada through Genome Canada (#13529) and the Canadian Institutes of Health Research (#155865), the Ministère de l’Économie et de l'Innovation du Québec through Genome Québec, the Quebec Breast Cancer Foundation, the CHU de Quebec Foundation and the Ontario Research Fund; and by the NIHR Cambridge Biomedical Research Centre (BRC-1215–20014). BCAC is funded by the European Union's Horizon 2020 Research and Innovation Programme (grant numbers 634935 and 633784 for BRIDGES and B-CAST respectively), and the PERSPECTIVE I&I project. Additional funding for BCAC is provided via the Confluence project which is funded with intramural funds from the NCI Intramural Research Program, NIH. Genotyping of the OncoArray was funded by the NIH Grant U19 CA148065, and Cancer Research UK Grant C1287/A16563 and the PERSPECTIVE project supported by the Government of Canada through Genome Canada and the Canadian Institutes of Health Research (grant GPH-129344) and, the Ministère de l’Économie, Science et Innovation du Québec through Genome Québec and the PSRSIIRI-701 grant, and the Quebec Breast Cancer Foundation. MT was supported by the NIHR Cambridge Biomedical Research Centre (BRC-1215–20014) and Cancer Research UK C22770/A31523 (International Alliance for Cancer Early Detection programme). The PRISMA study has been funded by Instituto de Salud Carlos III through the project " PI19/01195″ (Co-funded by European Regional Development Fund "A way to make Europe") and it received the institutional support of CERCA Program (Generalitat de Catalunya). The publication costs of this article were defrayed in part by the payment of publication fees. Therefore, and solely to indicate this fact, this article is hereby marked “advertisement” in accordance with 18 USC section 1734.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

  • Coignard, Juliette
  • Beesley, Jonathan
  • O'Mara, Tracy A.
  • Diez Gibert, Orland
  • Lopez-Fernandez, Adrià
  • Dennis, Joe
  • Tyrer, Jonathan
  • Lush, Michael
Càncer de mama; Genètica del càncer; Factors de risc, Cáncer de mama; Genética del cáncer; Factores de riesgo, Breast cancer; Cancer genetics; Risk factors, Breast cancer (BC) risk for BRCA1 and BRCA2 mutation carriers varies by genetic and familial factors. About 50 common variants have been shown to modify BC risk for mutation carriers. All but three, were identified in general population studies. Other mutation carrier-specific susceptibility variants may exist but studies of mutation carriers have so far been underpowered. We conduct a novel case-only genome-wide association study comparing genotype frequencies between 60,212 general population BC cases and 13,007 cases with BRCA1 or BRCA2 mutations. We identify robust novel associations for 2 variants with BC for BRCA1 and 3 for BRCA2 mutation carriers, P < 10−8, at 5 loci, which are not associated with risk in the general population. They include rs60882887 at 11p11.2 where MADD, SP11 and EIF1, genes previously implicated in BC biology, are predicted as potential targets. These findings will contribute towards customising BC polygenic risk scores for BRCA1 and BRCA2 mutation carriers.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

  • Pujana Genestar, M. Ángel
  • Teulé-Vega, Àlex
  • GEMO Study Collaborators
  • EMBRACE Collaborators
  • KConFab Investigators
  • HEBON Investigators
  • ABCTB Investigators
Breast cancer (BC) risk for BRCA1 and BRCA2 mutation carriers varies by genetic and familial factors. About 50 common variants have been shown to modify BC risk for mutation carriers. All but three, were identified in general population studies. Other mutation carrier-specific susceptibility variants may exist but studies of mutation carriers have so far been underpowered. We conduct a novel case-only genome-wide association study comparing genotype frequencies between 60,212 general population BC cases and 13,007 cases with BRCA1 or BRCA2 mutations. We identify robust novel associations for 2 variants with BC for BRCA1 and 3 for BRCA2 mutation carriers, P < 10-8, at 5 loci, which are not associated with risk in the general population. They include rs60882887 at 11p11.2 where MADD, SP11 and EIF1, genes previously implicated in BC biology, are predicted as potential targets. These findings will contribute towards customising BC polygenic risk scores for BRCA1 and BRCA2 mutation carriers.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

  • Zhan, Haoyu
  • Ahearn, Thomas U.
  • Lecarpentier, Julie
  • Lázaro García, Conxi
  • EMBRACE Collaborators
  • GEMO Study Collaborators
Genome-wide analysis identifies 32 loci associated with breast cancer susceptibility, accounting for estrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 status and tumor grade. Breast cancer susceptibility variants frequently show heterogeneity in associations by tumor subtype(1-3). To identify novel loci, we performed a genome-wide association study including 133,384 breast cancer cases and 113,789 controls, plus 18,908 BRCA1 mutation carriers (9,414 with breast cancer) of European ancestry, using both standard and novel methodologies that account for underlying tumor heterogeneity by estrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 status and tumor grade. We identified 32 novel susceptibility loci (P < 5.0 x 10(-8)), 15 of which showed evidence for associations with at least one tumor feature (false discovery rate < 0.05). Five loci showed associations (P < 0.05) in opposite directions between luminal and non-luminal subtypes. In silico analyses showed that these five loci contained cell-specific enhancers that differed between normal luminal and basal mammary cells. The genetic correlations between five intrinsic-like subtypes ranged from 0.35 to 0.80. The proportion of genome-wide chip heritability explained by all known susceptibility loci was 54.2% for luminal A-like disease and 37.6% for triple-negative disease. The odds ratios of polygenic risk scores, which included 330 variants, for the highest 1% of quantiles compared with middle quantiles were 5.63 and 3.02 for luminal A-like and triple-negative disease, respectively. These findings provide an improved understanding of genetic predisposition to breast cancer subtypes and will inform the development of subtype-specific polygenic risk scores.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer

  • Lázaro García, Conxi
  • ProCURE
  • Genetic Counseling Unit, Hereditary Cancer Program
Most common breast cancer susceptibility variants have been identified through genome-wide association studies (GWAS) of predominantly estrogen receptor (ER)-positive disease(1). We conducted a GWAS using 21,468 ER-negative cases and 100,594 controls combined with 18,908 BRCA1 mutation carriers (9,414 with breast cancer), all of European origin. We identified independent associations at P < 5 x 10(-8) with ten variants at nine new loci. At P < 0.05, we replicated associations with 10 of 11 variants previously reported in ER-negative disease or BRCA1 mutation carrier GWAS and observed consistent associations with ER-negative disease for 105 susceptibility variants identified by other studies. These 125 variants explain approximately 16% of the familial risk of this breast cancer subtype. There was high genetic correlation (0.72) between risk of ER-negative breast cancer and breast cancer risk for BRCA1 mutation carriers. These findings may lead to improved risk prediction and inform further fine-mapping and functional work to better understand the biological basis of ER-negative breast cancer.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer

  • Lázaro García, Conxi
  • GC-HBOC Study Collaborators
  • GEMO Study Collaborators
  • EMBRACE Collaborators
  • HEBON Investigators
  • BCFR Investigators
  • ABCTB Investigators
Genome-wide association studies (GWAS) have identified more than 170 breast cancer susceptibility loci. Here we hypothesize that some risk-associated variants might act in non-breast tissues, specifically adipose tissue and immune cells from blood and spleen. Using expression quantitative trait loci (eQTL) reported in these tissues, we identify 26 previously unreported, likely target genes of overall breast cancer risk variants, and 17 for estrogen receptor (ER)-negative breast cancer, several with a known immune function. We determine the directional effect of gene expression on disease risk measured based on single and multiple eQTL. In addition, using a gene-based test of association that considers eQTL from multiple tissues, we identify seven (and four) regions with variants associated with overall (and ER-negative) breast cancer risk, which were not reported in previous GWAS. Further investigation of the function of the implicated genes in breast and immune cells may provide insights into the etiology of breast cancer.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A saturated map of common genetic variants associated with human height

  • Yengo, Loic|||0000-0002-4272-9305
  • Vedantam, Sailaja|||0000-0003-3892-7461
  • Marouli, Eirini|||0000-0001-6179-1609
  • Sidorenko, Julia
  • Bartell, Eric
  • Sakaue, Saori|||0000-0003-3618-9717
  • Graff, Marielisa
  • Eliasen, Anders U.
  • Jiang, Yunxuan
  • Raghavan, Sridharan
  • Miao, Jenkai
  • Arias, Joshua D.
  • Graham, Sarah E.|||0000-0003-1271-2489
  • Mukamel, Ronen E.
  • Spracklen, Cassandra N.|||0000-0003-3590-7182
  • Yin, Xianyong|||0000-0001-6454-2384
  • Chen, Shyh-Huei
  • Ferreira, Teresa
  • Highland, Heather H.
  • Ji, Yingjie
  • Karaderi, Tugce|||0000-0001-9763-8139
  • Lin, Kuang
  • Lüll, Kreete
  • Malden, Deborah|||0000-0003-0567-8294
  • Medina-Gomez, Carolina|||0000-0001-7999-5538
  • Machado, Moara
  • Moore, Amy
  • Rüeger, Sina
  • Sim, Xueling|||0000-0002-1233-7642
  • Vrieze, Scott
  • Ahluwalia, Tarunveer Singh|||0000-0002-7464-3354
  • Akiyama, Masato|||0000-0002-1879-5476
  • Allison, Matthew A.
  • Álvarez, Marcus
  • Andersen, Mette korre|||0000-0001-8227-1469
  • Ani, Alireza|||0000-0002-7868-3118
  • Appadurai, Vivek
  • Arbeeva, Liubov|||0000-0001-5004-419X
  • Bhaskar, Seema
  • Bielak, Lawrence F.|||0000-0002-3443-8030
  • Bollepalli, Sailalitha|||0000-0002-8773-7149
  • Bonnycastle, Lori L.
  • Bork-Jensen, Jette
  • Bradfield, Jonathan Paul|||0000-0001-8758-2071
  • Bradford, Yuki
  • Braund, Peter S.|||0000-0001-8540-5709
  • Brody, Jennifer A.|||0000-0001-8509-148X
  • Burgdorf, Kristoffer S.
  • Cade, Brian E.|||0000-0003-1424-0673
  • Cai, H.
  • Cai, Qiuyin
  • Campbell, Archie|||0000-0003-0198-5078
  • Cañadas-Garre, Marisa|||0000-0003-1103-5658
  • Catamo, Eulalia|||0000-0002-4701-9134
  • Chai, Jin-Fang|||0000-0003-3770-1137
  • Chai, Xiaoran
  • Chang, Liching
  • Chang, Yicheng
  • Chen, Chien Hsiun
  • Chesi, Alessandra|||0000-0002-0954-7446
  • Choi, Seunghoan
  • Chung, Renhua
  • Cocca, Massimiliano|||0000-0002-1127-7596
  • Concas, Maria Pina|||0000-0003-3598-2537
  • Couture, Christian Y.
  • Cuellar-Partida, Gabriel|||0000-0001-7648-4097
  • Danning, Rebecca D.
  • Daw, E. Warwick
  • Degenhard, Frauke
  • Delgado, Graciela E.|||0000-0002-1272-7210
  • Delitala, Alessandro|||0000-0003-1729-8969
  • Demirkan, Ayşe|||0000-0002-7546-0867
  • Deng, Xuan|||0000-0003-0918-817X
  • Devineni, Poornima
  • Dietl, Alexander|||0000-0002-4091-8620
  • Dimitriou, Maria E.
  • Dimitrov, Latchezar M.
  • Dorajoo, Rajkumar|||0000-0001-6608-2051
  • Ekici, Arif B.
  • Engmann, Jorgen|||0000-0001-7015-7773
  • Fairhurst-Hunter, Zammy
  • Farmaki, Aliki Eleni
  • Faul, Jessica D.|||0000-0002-6969-6478
  • Fernandez-Lopez, Juan Carlos|||0000-0003-3680-4193
  • Forer, Lukas|||0000-0003-2139-7329
  • Francescatto, Margherita
  • Freitag-Wolf, Sandra
  • Fuchsberger, Christian|||0000-0002-5918-8947
  • Galesloot, Tessel E.
  • Gao, Yan
  • Gao, Zishan|||0000-0003-1299-0286
  • Geller, Frank
  • Giannakopoulou, Olga
  • Giulianini, Franco
  • Gjesing, Anette Prior
  • Goel, Anuj|||0000-0003-2307-4021
  • Gordon, Scott D.|||0000-0001-7623-328X
  • Gorski, Mathias M.
  • Grove, Jakob|||0000-0003-2284-5744
  • Guo, Xiuqing
  • Gustafsson, S.|||0000-0001-5894-0351
  • Haessler, Jeffrey W.
  • Hansen, Thomas Folkmann
  • Havulinna, Aki Samuli
  • Haworth, S.J.
  • He, Jing
  • Heard-Costa, Nancy L.
  • Hebbar, Prashantha|||0000-0001-6560-7063
  • Hindy, George|||0000-0002-7257-9299
  • Ho, Yuk Lam Anne
  • Hofer, Edith
  • Holliday, Elizabeth|||0000-0002-4066-6224
  • Horn, Katrin
  • Hornsby, Whitney E.
  • Hottenga, Jouke Jan|||0000-0002-5668-2368
  • Huang, Hongyan
  • Huang, Jie
  • Huerta-Chagoya, Alicia|||0000-0001-6218-3904
  • Huffman, Jennifer E.|||0000-0002-9672-2491
  • Hung, Yijen
  • Huo, Shaofeng
  • Hwang, Mi-yeong
  • Iha, Hiroyuki|||0000-0003-4261-2067
  • Ikeda, Daisuke D.|||0000-0001-8403-0327
  • Isono, Masato
  • Jackson, Anne U.|||0000-0002-9672-2547
  • Jäger, Susanne
  • Jansen, Iris E.|||0000-0003-1901-8131
  • Johansson, Ingegerd
  • Jonas, Jost Bruno
  • Jonsson, Anna Elisabet
  • Jørgensen, Torben J.
  • Kalafati, IP.|||0000-0001-5572-7491
  • Kanai, Masahiro|||0000-0001-5165-4408
  • Kanoni, Stavroula|||0000-0002-1691-9615
  • Kårhus, Line Lund
  • Kasturiratne, Anuradhani
  • Katsuya, Tomohiro|||0000-0002-8892-8828
  • Kawaguchi, Takahisa
  • Kember, Rachel L.|||0000-0001-8820-2659
  • Kentistou, Katherine A.|||0000-0002-5816-664X
  • Kim, Hanna
  • Kim, Young-jin
  • Kleber, Marcus Edi
  • Knol, Maria J.|||0000-0002-3597-1531
  • Kurbasic, Azra
  • Lauzon, Marie
  • Le, Phuong
  • Lea, Rodney A.
  • Lee, Jongyoung
  • Leonard, Hampton L.|||0000-0003-2390-8110
  • Li, Shengchao Alfred
  • Li, Xiaoyin
  • Liang, Jingjing
  • Lin, Honghuang
  • Lin, Shihyi
  • Liu, Jun|||0000-0001-5288-3042
  • Liu, Xueping
  • Lo, Ken Sin
  • Long, Jirong
  • Lores-Motta, Laura
  • Luan, Jian'fan N. An
  • Lyssenko, Valeriya
  • Lyytikäinen, Leo Pekka
  • Mahajan, Anubha|||0000-0001-5585-3420
  • Mamakou, Vasiliki
  • Mangino, Massimo
  • Manichaikul, Ani W.
  • Marten, Jonathan|||0000-0001-6916-2014
  • Mattheisen, Manuel|||0000-0002-8442-493X
  • Mavarani, Laven
  • McDaid, Aaron F.
  • Meidtner, Karina
  • Melendez, Tori L.
  • Mercader, Josep M.|||0000-0001-8494-3660
  • Milaneschi, Yuri|||0000-0002-3697-6617
  • Miller, Jason E.
  • Millwood, Iona Y.
  • Mishra, Pashupati P.|||0000-0001-5177-3431
  • Mitchell, Ruth E.
  • Møllehave, Line Tang|||0000-0001-7116-9346
  • Morgan, Anna
  • Mucha, Soeren
  • Munz, Matthias|||0000-0002-4728-3357
  • Nakatochi, Masahiro|||0000-0002-1838-4837
  • Nelson, Christopher P.
  • Nethander, Maria
  • Nho, Chu Won
  • Nielsen, Aneta A.
  • Nolte, Ilja M.|||0000-0001-5047-4077
  • Nongmaithem, Suraj S.|||0000-0001-5390-0449
  • Noordam, Raymond|||0000-0001-7801-809X
  • Ntalla, Ioanna
  • Nutile, Teresa
  • Pandit, Anita
  • Christofidou, Paraskevi
  • Pärna, Katri
  • Pauper, Marc
  • Petersen, Eva R.B.
  • Petersen, Liselotte V.
  • Pitkänen, Niina
  • Polašek, Ozren
  • Poveda, Alaitz|||0000-0001-6349-3955
  • Preuss, Michael H.
  • Pyarajan, Saiju
  • Raffield, Laura M.
  • Rakugi, Hiromi
  • Ramirez, Julia
  • Rasheed, Asif
  • Raven, Dennis
  • Rayner, Nigel W.
  • Riveros, Carlos
  • Rohde, Rebecca
  • Ruggiero, Daniela|||0000-0003-3898-7827
  • Ruotsalainen, Sanni E.|||0000-0002-1631-4069
  • Ryan, Kathleen A.
  • Sabater-Lleal, Maria|||0000-0002-0128-379X
  • Saxena, Richa
  • Scholz, Markus|||0000-0002-4059-1779
  • Sendamarai, Anoop
  • Shen, Botong
  • Shi, Jingchunzi
  • Shin, J.H.
  • Sidore, Carlo|||0000-0001-7504-7477
  • Sitlani, Collen M.|||0000-0001-7656-7482
  • Slieker, Roderick C.
  • Smit, Roelof A. J.
  • Smith, Albert V.
  • Smith, Jennifer A.|||0000-0002-3575-5468
  • Smyth, Laura J.|||0000-0001-6419-4826
  • Southam, Lorraine
  • Steinthorsdottir, Valgerdur
  • Sun, Liang
  • Takeuchi, Fumihiko
  • Tallapragada, Divya Sri Priyanka
  • Taylor, Kent|||0000-0002-2756-4370
  • Tayo, Bamidele O.
  • Tcheandjieu, Catherine
  • Terzikhan, Natalie
  • Tesolin, Paola|||0000-0002-5238-6422
  • Teumer, Alexander|||0000-0002-8309-094X
  • Theusch, Elizabeth|||0000-0002-5678-759X
  • Thompson, Deborah J.
  • Thorleifsson, Gudmar|||0000-0003-4623-9087
  • Timmers, Paul R. H. J.
  • Trompet, Stella|||0000-0001-5006-0528
  • Turman, Constance
  • Vaccargiu, Simona
  • van der Laan, Sander W.|||0000-0001-6888-1404
  • van der Most, Peter J.|||0000-0001-8450-3518
  • van Klinken, Jan Bert
  • van Setten, Jessica A.
  • Verma, Shefali Setia
  • Verweij, Niek|||0000-0002-4303-7685
  • Veturi, Yogasudha C.
  • Wang, Carol A.|||0000-0002-4301-3974
  • Wang, Chaolong
  • Wang, Lihua
  • Wang, Zhe|||0000-0003-0786-9887
  • Warren, Helen R.
  • Bin Wei, Wen
  • Wickremasinghe, Ananda|||0000-0002-6174-6784
  • Wielscher, Matthias|||0000-0003-4138-1383
  • Wiggins, Kerri L.|||0000-0003-2749-1279
  • Winsvold, Bendik Slagsvold|||0000-0003-4171-8919
  • Wong, Andrew|||0000-0003-2079-4779
  • Wu, Yang|||0000-0002-0128-7280
  • Wuttke, Matthias|||0000-0003-3420-5082
  • Xia, Rui|||0000-0003-2409-1181
  • Xie, Tian
  • Yamamoto, Ken
  • Yang, Jingyun
  • Yao, Jie
  • Young, Hannah|||0000-0002-4248-9612
  • Yousri, Noha A.|||0000-0003-1918-0331
  • Yu, Lei
  • Zeng, Lingyao
  • Zhang, Weihua
  • Zhang, Xinyuan
  • Zhao, Jinghua
  • Zhao, Wei|||0000-0002-4839-6791
  • Zhou, Wei
  • Zimmermann, Martina E.|||0000-0002-6916-4404
  • Zoledziewska, Magdalena|||0000-0002-3033-6133
  • Adair, Linda S.
  • Adams, Hieab H. H.|||0000-0003-3687-2508
  • Aguilar-Salinas, Carlos Alberto
  • Al-Mulla, Fahd|||0000-0001-5409-3829
  • Arnett, Donna|||0000-0003-2219-657X
  • Asselbergs, Folkert W.|||0000-0002-1692-8669
  • Åsvold, Bjørn Olav|||0000-0003-3837-2101
  • Attia, John Richard
  • Banas, Bernhard|||0000-0003-2076-2195
  • Bandinelli, Stefania|||0000-0002-6491-0850
  • Bennett, David Alan
  • Bergler, Tobias
  • Bharadwaj, Dwaipayan
  • Biino, Ginevra|||0000-0002-9936-946X
  • Bisgaard, Hans
  • Boerwinkle, Eric|||0000-0001-8813-0544
  • Böger, Carsten A.
  • Bønnelykke, Klaus
  • Boomsma, Dorret I.|||0000-0002-7099-7972
  • Børglum, Anders D.|||0000-0001-8627-7219
  • Borja, Judith B.
  • Bouchard, Claude|||0000-0002-0048-491X
  • Bowden, Donald W.
  • Brandslund, Ivan
  • Brumpton, Ben
  • Buring, Julie E.
  • Caulfield, Mark|||0000-0001-9295-3594
  • Chambers, John C.
  • Chandak, Giriraj R.
  • Chanock, Stephen|||0000-0002-2324-3393
  • Chaturvedi, Nish
  • Chen, Yii Der Ida
  • Chen, Zhengming|||0000-0001-6423-105X
  • Cheng, Ching-Yu|||0000-0003-0655-885X
  • Christophersen, Ingrid E.
  • Ciullo, Marina|||0000-0002-9621-9984
  • Cole, John W.|||0000-0001-9263-8930
  • Collins, Francis S.|||0000-0002-1023-7410
  • Cooper, Richard S.
  • Cruz, Miguel
  • Cucca, Francesco|||0000-0002-7414-1995
  • Cupples, L. Adrienne
  • Cutler, Michael J.
  • Damrauer, Scott M.|||0000-0001-8009-1632
  • Dantoft, Thomas M.
  • de Borst, Gert J.
  • de Groot, Lisette C.P.G.M.|||0000-0003-2778-2789
  • De Jager, Philip L.|||0000-0002-8057-2505
  • de Kleijn, D.P.V.|||0000-0003-2714-2140
  • Janaka de Silva, H.
  • Dedoussis, George V.
  • den Hollander, Anneke I.
  • Du, Shufa
  • Easton, Douglas F.|||0000-0003-2444-3247
  • Elders, Petra J. M.
  • Eliassen, A. Heather Heather
  • Ellinor, Patrick T.
  • Elmståhl, Sölve
  • Erdmann, Jeanette|||0000-0002-4486-6231
  • Evans, Michele K.
  • Fatkin, Diane
  • Feenstra, Bjarke|||0000-0003-1478-649X
  • Feitosa, Mary|||0000-0002-0933-2410
  • Ferrucci, Luigi
  • Ford, Ian
  • Fornage, Myriam|||0000-0003-0677-8158
  • Franke, Andre|||0000-0003-1530-5811
  • Franks, Paul W.|||0000-0002-0520-7604
  • Freedman, Barry I.|||0000-0003-0275-5530
  • Gasparini, Paolo
  • Gieger, Christian|||0000-0001-6986-9554
  • Girotto, Giorgia|||0000-0003-4507-6589
  • Goddard, Michael E.
  • Golightly, Yvonne M.
  • Gonzalez-Villalpando, Clicerio
  • Gordon-Larsen, P.
  • Grallert, H.
  • Grant, Struan F. A.|||0000-0003-2025-5302
  • Grarup, Niels|||0000-0001-5526-1070
  • Griffiths, L.
  • Gudnason, V.
  • Haiman, C.
  • Hakonarson, Hakon|||0000-0003-2814-7461
  • Hansen, Torben|||0000-0001-8748-3831
  • Hartman, C.A.
  • Hattersley, A.T.
  • Hayward, Caroline|||0000-0002-9405-9550
  • Heckbert, S.R.
  • Heng, C.K.
  • Hengstenberg, C.
  • Hewitt, Alex W.|||0000-0002-5123-5999
  • Hishigaki, H.
  • Hoyng, C.B.
  • Huang, Paul L.
  • Huang, W.
  • Hunt, S.C.
  • Hveem, K.
  • Hyppönen, E.
  • Iacono, William
  • Ichihara, S.
  • Ikram, M.A.
  • Isasi, C.R.
  • Jackson, R.D.
  • Jarvelin, Marjo-Riitta|||0000-0002-2149-0630
  • Jin, Zi-Bing
  • Jöckel, K.H.
  • Joshi, P.K.
  • Jousilahti, P.
  • Jukema, J.W.
  • Kähönen, M.
  • Kamatani, Yoichiro|||0000-0001-8748-5597
  • Kang, K.D.
  • Kaprio, Jaakko|||0000-0002-3716-2455
  • Kardia, S.L.R.
  • Karpe, F.
  • Kato, N.
  • Kee, F.
  • Kessler, T.
  • Khera, Amit V.
  • Khor, C.C.
  • Kiemeney, Lambertus A.
  • Kim, B.J.
  • Kim, E.K.
  • Kim, H.L.
  • Kirchhof, P.
  • Kivimaki, Mika|||0000-0002-4699-5627
  • Koh, W.P.
  • Koistinen, H.A.
  • Kolovou, G.D.
  • Kooner, J.S.
  • Kooperberg, C.
  • Köttgen, A.
  • Kovacs, P.
  • Kraaijeveld, A.
  • Kraft, Peter
  • Krauss, R.M.
  • Kumari, M.
  • Kutalik, Zoltan|||0000-0001-8285-7523
  • Laakso, Markku|||0000-0002-3394-7749
  • Lange, Leslie A.
  • Langenberg, C.
  • Launer, L.J.
  • Le Marchand, L.
  • Lee, H.
  • Lee, N.R.
  • Lehtimäki, T.
  • Li, H.
  • Li, L.
  • Lieb, Wolfgang|||0000-0003-2544-4460
  • Lin, X.
  • Lind, Lars
  • Linneberg, Allan|||0000-0002-0994-0184
  • Liu, Ching-Ti
  • Liu, Jianjun|||0000-0002-3255-3019
  • Loeffler, Markus
  • London, Barry
  • Lubitz, Steven A.
  • Lye, Stephen J.
  • Mackey, David A.
  • Mägi, Reedik
  • Magnusson, Patrik K. E.|||0000-0002-7315-7899
  • Marcus, Gregory M.|||0000-0001-5197-7696
  • Vidal, Pedro M.
  • Martin, Nicholas G.|||0000-0003-4069-8020
  • März, Winfried|||0000-0001-6083-8946
  • Matsuda, Fumihiko
  • McGarrah, Robert W.
  • McGue, Matt|||0000-0002-5580-1433
  • McKnight, Amy Jayne|||0000-0002-7482-709X
  • Medland, Sarah Elizabeth|||0000-0003-1382-380X
  • Mellström, Dan|||0000-0003-2761-3723
  • Metspalu, Andres|||0000-0002-3718-796X
  • Mitchell, Braxton|||0000-0003-4920-4744
  • Mitchell, Paul
  • Mook-Kanamori, Dennis O.
  • Morris, Andrew D.
  • Mucci, Lorelei A.
  • Munroe, Patricia B.|||0000-0002-4176-2947
  • Nalls, Mike A.
  • Nazarian, Saman
  • Nelson, Amanda E.
  • Neville, Matt J.|||0000-0002-6004-5433
  • Newton-Cheh, Christopher
  • Nielsen, Christopher S.
  • Nöthen, Markus M.|||0000-0002-8770-2464
  • Ohlsson, Claes|||0000-0002-9633-2805
  • Oldehinkel, Albertine J.|||0000-0003-3925-3913
  • Orozco, Lorena|||0000-0002-5801-9180
  • Pahkala, Katja
  • Pajukanta, Päivi
  • Palmer, Colin N. A.
  • Parra, Esteban J.|||0000-0002-2057-8577
  • Pattaro, Cristian|||0000-0002-4119-0109
  • Pedersen, Oluf
  • Pennell, Craig E.|||0000-0002-0937-6165
  • Penninx, Brenda W. J. H.
  • Pérusse, Louis|||0000-0001-6440-9698
  • Peters, Annette|||0000-0001-6645-0985
  • Peyser, Patricia A.
  • Porteous, David J.|||0000-0003-1249-6106
  • Posthuma, Danielle|||0000-0001-7582-2365
  • Power, Chris
  • Pramstaller, Peter P.
  • Province, Michael A.|||0000-0001-6102-774X
  • Qi, Qibin
  • Qu, Jia
  • Rader, Daniel J.
  • Raitakari, Olli T.
  • Ralhan, Sarju
  • Rallidis, Loukianos S.
  • Rao, Dabeeru C.
  • Redline, Susan
  • Reilly, Dermot F.
  • Reiner, Alexander P.
  • Rhee, Sang Youl|||0000-0003-0119-5818
  • Ridker, Paul M.
  • Rienstra, Michiel|||0000-0002-2581-070X
  • Ripatti, Samuli|||0000-0002-0504-1202
  • Ritchie, Marylyn D.|||0000-0002-1208-1720
  • Roden, Dan M.
  • Rosendaal, Frits|||0000-0003-2558-7496
  • Rotter, Jerome I.|||0000-0001-7191-1723
  • Rudan, Igor|||0000-0001-6993-6884
  • Rutters, Femke
  • Sabanayagam, Charumathi|||0000-0002-4042-4719
  • Saleheen, Danish|||0000-0001-6193-020X
  • Salomaa, Veikko|||0000-0001-7563-5324
  • Samani, Nilesh J.
  • Sanghera, Dharambir K.
  • Sattar, Naveed|||0000-0002-1604-2593
  • Schmidt, Börge
  • Schmidt, Helena|||0000-0001-9773-9992
  • Schmidt, Reinhold
  • Schulze, Matthias B.
  • Schunkert, Heribert|||0000-0001-6428-3001
  • Scott, Laura J.|||0000-0002-4886-5084
  • Scott, Rodney J.|||0000-0001-7724-3404
  • Sever, Peter
  • Shiroma, Eric J.
  • Shoemaker, M. Benjamin
  • Shu, Xiao-Ou
  • Simonsick, Eleanor M.
  • Sims, Mario
  • Singh, Jai Rup
  • Singleton, Andrew B.|||0000-0001-5606-700X
  • Sinner, Moritz F.
  • Smith, J. Gustav
  • Snieder, Harold|||0000-0003-1949-2298
  • Spector, Tim|||0000-0002-9795-0365
  • Stampfer, Meir J.
  • Stark, Klaus J.
  • Strachan, David P.
  • 't Hart, Leen M.
  • Tabara, Yasuharu
  • Tang, Hua
  • Tardif, J.C.
  • Thanaraj, T.A.
  • Timpson, N.J.
  • Tönjes, A.
  • Tremblay, A.
  • Tuomi, T.
  • Tuomilehto, J.
  • Tusié-Luna, M.T.
  • Uitterlinden, André G.|||0000-0002-7276-3387
  • van Dam, Rob M.
  • van der Harst, Pim|||0000-0002-2713-686X
  • Van der Velde, Nathalie
  • van Duijn, Cornelia M.|||0000-0002-2374-9204
  • van Schoor, N.M.
  • Vitart, Veronique|||0000-0002-4991-3797
  • Völker, U.
  • Vollenweider, P.
  • Völzke, Henry|||0000-0001-7003-399X
  • Wacher-Rodarte, N.H.
  • Walker, M.
  • Wang, Y.X.
  • Wareham, N.J.
  • Watanabe, R.M.
  • Watkins, Hugh
  • Weir, D.R.
  • Werge, Thomas M.
  • Widen, E.
  • Wilkens, Lynne R.
  • Willemsen, Gonneke|||0000-0003-3755-0236
  • Willett, Walter C.
  • Wilson, James F.|||0000-0001-5751-9178
  • Wong, Tien-Yin
  • Woo, Jeong-Taek|||0000-0001-9201-0713
  • Wright, Alan F.
  • Wu, Jer-Yuarn
  • Xu, Huichun|||0000-0001-8118-9607
  • Yajnik, Chittaranjan S.
  • Yokota, Mitsuhiro
  • Yuan, Jian-Min|||0000-0002-4620-3108
  • Zeggini, Eleftheria|||0000-0003-4238-659X
  • Zemel, Babette S.
  • Zheng, Wei|||0000-0003-1226-070X
  • Zhu, X.|||0000-0003-0037-411X
  • Zmuda, Joseph M.
  • Zonderman, Alan B.|||0000-0002-6523-4778
  • Zwart, John-Anker|||0000-0001-5721-0154
  • Croteau-Chonka, Damien
  • Vonk, Judith M.
  • Le Marchand, Loic
  • Chasman, Daniel I.|||0000-0003-3357-0862
  • Cho, Yoon Shin
  • Heid, Iris M.
  • McCarthy, Mark I.
  • Ng, Maggie C. Y.
  • O'Donnell, Christopher J.
  • Rivadeneira, Fernando|||0000-0001-9435-9441
  • Thorsteinsdottir, Unnur
  • Sun, Yan V.|||0000-0002-2838-1824
  • Tai, E. Shyong
  • Boehnke, Michael|||0000-0002-6442-7754
  • Deloukas, Panos|||0000-0001-9251-070X
  • Justice, Anne E.
  • Lindgren, Cecilia M.
  • Loos, Ruth J. F.|||0000-0002-8532-5087
  • Mohlke, Karen L.|||0000-0001-6721-153X
  • North, Kari E.
  • Stefánsson, Kári|||0000-0003-1676-864X
  • Walters, Robin G.|||0000-0002-9179-0321
  • Winkler, Thomas W.|||0000-0003-0292-5421
  • Young, Kristin L.|||0000-0003-0070-6145
  • Loh, Po-Ru
  • Yang, Jian|||0000-0003-4800-832X
  • Esko, Tõnu
  • Assimes, Themistocles|||0000-0003-2349-0009
  • Auton, Adam
  • Abecasis, Goncalo
  • Willer, Cristen J.|||0000-0001-5645-4966
  • Locke, Adam E.|||0000-0001-6227-198X
  • Berndt, Sonja
  • Lettre, Guillaume
  • Frayling, Timothy M.
  • Okada, Yukinori|||0000-0002-0311-8472
  • Wood, Andrew R.|||0000-0003-1726-948X
  • Visscher, PM.|||0000-0002-2143-8760
  • Hirschhorn, Joel N.|||0000-0002-1650-7901
Common single-nucleotide polymorphisms (SNPs) are predicted to collectively explain 40-50% of phenotypic variation in human height, but identifying the specific variants and associated regions requires huge sample sizes. Here, using data from a genome-wide association study of 5.4 million individuals of diverse ancestries, we show that 12,111 independent SNPs that are significantly associated with height account for nearly all of the common SNP-based heritability. These SNPs are clustered within 7,209 non-overlapping genomic segments with a mean size of around 90 kb, covering about 21% of the genome. The density of independent associations varies across the genome and the regions of increased density are enriched for biologically relevant genes. In out-of-sample estimation and prediction, the 12,111 SNPs (or all SNPs in the HapMap 3 panel) account for 40% (45%) of phenotypic variance in populations of European ancestry but only around 10-20% (14-24%) in populations of other ancestries. Effect sizes, associated regions and gene prioritization are similar across ancestries, indicating that reduced prediction accuracy is likely to be explained by linkage disequilibrium and differences in allele frequency within associated regions. Finally, we show that the relevant biological pathways are detectable with smaller sample sizes than are needed to implicate causal genes and variants. Overall, this study provides a comprehensive map of specific genomic regions that contain the vast majority of common height-associated variants. Although this map is saturated for populations of European ancestry, further research is needed to achieve equivalent saturation in other ancestries.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Incorporating Alternative Polygenic Risk Scores into the BOADICEA Breast Cancer Risk Prediction Model

  • Mavaddat, Nasim
  • Ficorella, Lorenzo
  • Carver, Tim
  • Lee, Andrew
  • Cunningham, Alex P.
  • Pardo Muñoz, Monica
  • Balmaña Gelpí, Judith
  • Lush, Michael
Polygenic risk; Prediction; Breast cancer, Riesgo poligénico; Predicción; Cáncer de mama, Risc poligènic; Predicció; Càncer de mama, Background: The multifactorial risk prediction model BOADICEA enables identification of women at higher or lower risk of developing breast cancer. BOADICEA models genetic susceptibility in terms of the effects of rare variants in breast cancer susceptibility genes and a polygenic component, decomposed into an unmeasured and a measured component - the polygenic risk score (PRS). The current version was developed using a 313 SNP PRS. Here, we evaluated approaches to incorporating this PRS and alternative PRS in BOADICEA. Methods: The mean, SD, and proportion of the overall polygenic component explained by the PRS (α2) need to be estimated. α was estimated using logistic regression, where the age-specific log-OR is constrained to be a function of the age-dependent polygenic relative risk in BOADICEA; and using a retrospective likelihood (RL) approach that models, in addition, the unmeasured polygenic component. Results: Parameters were computed for 11 PRS, including 6 variations of the 313 SNP PRS used in clinical trials and implementation studies. The logistic regression approach underestimates α⁠, as compared with the RL estimates. The RL α estimates were very close to those obtained by assuming proportionality to the OR per 1 SD, with the constant of proportionality estimated using the 313 SNP PRS. Small variations in the SNPs included in the PRS can lead to large differences in the mean. Conclusions: BOADICEA can be readily adapted to different PRS in a manner that maintains consistency of the model., This work has been supported by grants from Cancer Research UK (PPRPGM-Nov20\100002); the European Union's Horizon 2020 Research and Innovation Programme under grant agreement numbers 633784 (B-CAST) and 634935 (BRIDGES); the PERSPECTIVE I&I project which is funded by the Government of Canada through Genome Canada (#13529) and the Canadian Institutes of Health Research (#155865), the Ministère de l’Économie et de l'Innovation du Québec through Genome Québec, the Quebec Breast Cancer Foundation, the CHU de Quebec Foundation and the Ontario Research Fund; and by the NIHR Cambridge Biomedical Research Centre (BRC-1215–20014). BCAC is funded by the European Union's Horizon 2020 Research and Innovation Programme (grant numbers 634935 and 633784 for BRIDGES and B-CAST respectively), and the PERSPECTIVE I&I project. Additional funding for BCAC is provided via the Confluence project which is funded with intramural funds from the NCI Intramural Research Program, NIH. Genotyping of the OncoArray was funded by the NIH Grant U19 CA148065, and Cancer Research UK Grant C1287/A16563 and the PERSPECTIVE project supported by the Government of Canada through Genome Canada and the Canadian Institutes of Health Research (grant GPH-129344) and, the Ministère de l’Économie, Science et Innovation du Québec through Genome Québec and the PSRSIIRI-701 grant, and the Quebec Breast Cancer Foundation. MT was supported by the NIHR Cambridge Biomedical Research Centre (BRC-1215–20014) and Cancer Research UK C22770/A31523 (International Alliance for Cancer Early Detection programme). The PRISMA study has been funded by Instituto de Salud Carlos III through the project " PI19/01195″ (Co-funded by European Regional Development Fund "A way to make Europe") and it received the institutional support of CERCA Program (Generalitat de Catalunya). The publication costs of this article were defrayed in part by the payment of publication fees. Therefore, and solely to indicate this fact, this article is hereby marked “advertisement” in accordance with 18 USC section 1734.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

  • Coignard, Juliette
  • Beesley, Jonathan
  • O'Mara, Tracy A.
  • Diez Gibert, Orland
  • Lopez Fernandez, Adrià
  • Dennis, Joe
  • Tyrer, Jonathan
  • Lush, Michael
Càncer de mama; Genètica del càncer; Factors de risc, Cáncer de mama; Genética del cáncer; Factores de riesgo, Breast cancer; Cancer genetics; Risk factors, Breast cancer (BC) risk for BRCA1 and BRCA2 mutation carriers varies by genetic and familial factors. About 50 common variants have been shown to modify BC risk for mutation carriers. All but three, were identified in general population studies. Other mutation carrier-specific susceptibility variants may exist but studies of mutation carriers have so far been underpowered. We conduct a novel case-only genome-wide association study comparing genotype frequencies between 60,212 general population BC cases and 13,007 cases with BRCA1 or BRCA2 mutations. We identify robust novel associations for 2 variants with BC for BRCA1 and 3 for BRCA2 mutation carriers, P < 10−8, at 5 loci, which are not associated with risk in the general population. They include rs60882887 at 11p11.2 where MADD, SP11 and EIF1, genes previously implicated in BC biology, are predicted as potential targets. These findings will contribute towards customising BC polygenic risk scores for BRCA1 and BRCA2 mutation carriers.